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Abstract 
Identification of microRNA Biogenesis Regulators and Activity Modulators 
Wei-Jen Chung 
 
MicroRNAs play a key role in post-transcriptional gene regulation. They regulate target 
gene expression with mRNA degradation or translation repression. Each miRNA is 
estimated to regulate dozens of genes in human, and dysregulation of miRNA leads to 
various diseases, such as cancer, heart disease and depression. Therefore, it is critical to 
understand the mechanism of miRNA biogenesis and targeting. This work integrated 
gene and miRNA expression profile from various cancer projects to screen for potential 
miRNA biogenesis regulators and activity modulators. In this analysis, we identified 
several genes that regulate miRNA biogenesis pathway and miRNA-mediated regulation. 
We also found the association between these genes and tumor progression. 
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MicroRNAs (miRNAs) have emerged as key regulators of both normal and 
pathologic phenotypes, including cancer (Yi, Pasolli et al. 2009). Fine-grained regulation 
of their biogenesis; however, is still poorly understood and only a few of their key 
regulators have been characterized. In order to understand the extent and specificity of 
miRNA-biogenesis control, as well as the role of miRNA-biogenesis regulators in 
tumorigenesis and cancer progression (van Kouwenhove, Kedde et al. 2011), we set out 
to identify these regulators and profile their targets. We developed an algorithm for 
genome-wide inference of miRNA-biogenesis regulators. We identified biogenesis 
regulator candidates by assessing the mutual information between mature miRNA 
expression and the expression of its transcription unit after conditioning for the 
expression of candidate biogenesis regulator. Thus the algorithm identifies genes whose 
expression correlates with deviations between mature miRNAs and their precursors. In 
addition to biogenesis, the miRNA targeting pathway is also extensively controlled with 
different mechanisms. Several regulators modulate miRNA activity by interacting with 
miRISC or binding to target mRNA (Lu, Getz et al. 2005). We developed an algorithm to 
genome-wide screen for non-sponge modulators that affect miRNA activity from 
validated miRNA-target interactions. The predicted modulators were experimentally 
validated to regulate miRNA activity via post-transcriptional mechanism. 
The intragenic miRNA and its host or neighboring mRNA or the miRNAs in the 
same transcription unit originate from the same nascent transcript (Kim and Kim 2007). 
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On the other hand, the miRNA-mediated regulation in animal is mainly through mRNA 
degradation (Bartel 2009). Therefore, the relationships between host and intragenic 
miRNA, miRNAs in the same cluster, or miRNA and target mRNA will be significantly 
correlated theoretically. However, the post-transcriptional biogenesis regulators and the 
miRNA modulators affect the level of mature miRNA (Krol, Loedige et al. 2010), and 
this suggests that the correlation between the host and intragenic miRNA, miRNAs in one 
cluster, or miRNA and target mRNA will be affected. The hypothesis is that we can 
identify genes whose expression profiles explain the discrepancy between the 
relationships, and the genes are involved in the pathway.  
MiRNAs participate in various biological pathways by post-transcriptionally 
suppress target genes. Their maturation and targeting pathways are finely regulated by 
post-transcriptional regulators (Siomi and Siomi 2010). Currently, all of the known 
miRNA biogenesis regulators and function modulators were identified individually with 
experiments, such as immuno-precipitation for physical evidence and silencing for 
functional study. This project is the first genome-wide effort to screen for the factors that 
are involved in miRNA biogenesis and targeting. Furthermore, we showed these 
candidate miRNA regulators associate with tumorigenesis and progression of 
glioblastoma through regulating miRNA maturation and function. 
We developed two algorithms, MIRAGE and Hermes, to identify miRNA 
biogenesis regulators and activity modulators, respectively. To identify miRNA 
biogenesis regulators, we first summarized intragenic miRNAs and host genes, or 
miRNA clusters with genomic coordinates, expression profiles and additional evidences. 
Secondly, MIRAGE predicted candidate biogenesis regulators by finding genes whose 
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expression is correlated with deviation in co-expression between miRNA and host using 
conditional mutual information. The candidate genes from all host-miRNA pairs were 
integrated by Fisher’s method (Fisher 1925). Finally, we selected several candidate 
biogenesis regulators for siRNA silencing or over-expression. The miRNA expression 
level was then measured by real-time PCR or array-based technology, such as Wafergen 
and Fluidigm. 
To identify miRNA function modulators, we collected miRNA-target interactions 
validated by low-throughput method, such as western blotting and luciferase assay. Then, 
Hermes screened for miRNA functional modulators by using conditional mutual 
information. We chose several candidates for silencing or over-expression; then measure 
the expression level of target mRNAs. In addition, we found EGFR, FYN and TRIM29 
possessing the same of mode of action from two independent data sets.  
Chapter 2 gives the introduction and review of current understanding about 
miRNA. It starts from the history of discovering miRNA followed by the mechanism of 
miRNA-mediated regulation and the control of miRNA maturation and activity from 
literatures. One main focus in miRNA field is to identify mRNAs targeted by miRNAs. 
This chapter also covers the current computational and experimental efforts to 
transcriptome-wide identify miRNA targets. Finally, we briefly reviewed the association 
of miRNAs and tumorigenesis, focusing on glioblastoma multiforme. 
Chapter 3 described the identification of miRNA promoter by integrating 
chromHMM data from ENCODE and CAGE-seq data from FANTOM (Ernst and Kellis 
2010; Ernst, Kheradpour et al. 2011). Chromatin profiling has emerged as an important 
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tool for genome annotation and detection of regulatory events. ENCODE carried out the 
profiling of histone modifications and CTCF binding sites, which all associate with 
different chromatin states. This chapter presents the list of intragenic miRNAs with 
independent promoters. The correlation between intragenic miRNAs and their hosts from 
different contexts were also summarized. 
Chapter 4 demonstrated the computational screening of miRNA post-
transcriptional regulators using gene and miRNA expression profile from TCGA 
glioblastoma data set (Lambertz, Nittner et al. 2010), then followed by functional and 
biochemical validation. Additionally, we examined the role of these candidates in cell 
proliferation and patient prognosis. 
Chapter 5 described the analysis of miRNA activity modulators using validated 
miRNA-target interactions and gene/miRNA expression profile from TCGA breast 
cancer, glioblastoma and METABRIC (Melo, Ropero et al. 2009; Paroo, Ye et al. 2009). 
We also showed the functional study of selected candidate miRNA modulators and 





Literature Review  
In 1993, the first miRNA, lin-4, was identified in C. elegans by screening for 
mutants that cause temporal development deficiency (Lee, Feinbaum et al. 1993). 
However, lin-4 was unable to be identified in closely related species because of the lack 
of genomic information and unsuccessful screening. Therefore, the regulation of lin-4 
was considered to be a C. elegans specific mechanism, until a highly conserved miRNA, 
let-7, and its orthologs in fly, mouse and human were identified in 2000 (Pasquinelli, 
Reinhart et al. 2000). In 2001, dozens of miRNAs were cloned from C. elegans, and 
miRNA started to be regarded as a new class of small RNA (Lagos-Quintana, Rauhut et 
al. 2001). Due to the special secondary structure of miRNA precursors, people predicted 
hundreds of miRNA from various model organisms. Later on, with the help of next 
generation sequencing, miRNAs were confirmed and identified with this technology. 
Currently, miRNAs have been identified in plants, animals and viruses, and there are 
more than 1400 miRNA genes have been identified in human (Kozomara and Griffiths-
Jones 2011). 
The first miRNA was discovered by screening mutant in C. elegans (Lee, 
Feinbaum et al. 1993). Eight years later, right after the first conserved miRNA, let-7, was 
identified, the first sets of miRNAs in worm, fly, and human were biochemically cloned 
(Lagos-Quintana, Rauhut et al. 2001; Newman, Thomson et al. 2008; Piskounova, 
Viswanathan et al. 2008). Generally, miRNAs possess several special features, including 
the hairpin-like secondary structure, evolutionary conservation, sequence biases in the 
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first five bases, the uniformed length of mature product and a tendency toward having 
symmetric internal loops and bulges in the miRNA region, and these features were used 
to predict miRNA in various organisms. Next generation sequencing was developed in 
the mid to late 1990s and was on market since 2004. Due to the read length (~50bp) and 
large quantities of data from high-throughput sequencing, scientists quickly applied this 
technology to identify various types of small RNAs, including miRNAs. Currently, 
miRBase records 24521 miRNA hairpin precursors, expressing 30424 mature miRNA 
products in 206 species, covering animals, plants and viruses, and human genome 
contains 1872 precursors, expressing 2578 mature miRNAs (Rybak, Fuchs et al. 2008). 
The miRNAs can be classified into intragenic and intergenic based on their 
genomic location: intragenic indicates the miRNA locates within the protein-coding gene, 
while intergenic means the miRNA is in the intergenic region. When the miRNA is 
expressed, the precursor will form a hairpin structure because of its sequence 
composition. At this step, the precursor is called “pri-miRNA”. DROSHA binds the pri-
miRNA and removes the stem and the basal single strand RNA region of the hairpin. 
DROSHA processing creates a two-nucleotide overhang at the 3’ end, and this structure 
is important for binding of TARBP2, an important downstream factor (Kim, Han et al. 
2009; Krol, Loedige et al. 2010; Siomi and Siomi 2010). Interestingly, DROSHA 
cleavage of intragenic miRNA is simultaneous with mRNA splicing (Kim and Kim 2007). 
DGCR8 binding at the junction of single strand RNA and hairpin facilitates DROSHA 
measuring the cleavage site to chop single strand RNA off (Han, Lee et al. 2006). There 
is another class of miRNA, called miRtron. This type of miRNAs is generated from small 
introns, normally short than 100 nucleotides. The entire intron can form a short hairpin 
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with two nucleotides overhang; therefore, it can bypass DROSHA cleavage and is 
transported to cytoplasm directly (Berezikov, Chung et al. 2007; Okamura, Hagen et al. 
2007; Ruby, Jan et al. 2007). After splicing, instead of being degraded, certain small 
introns will form a hairpin structure with two-nucleotide overhang at the 3’ end. MiRtron 
has a subtype called “tailed-miRtron”, which comes from a longer intron (Flynt, 
Greimann et al. 2010). This type of pri-miRNA has a hairpin structure with a long tail, 
and the tail is trimmed off by 3’->5’ exonuclease. This type of miRNA is able to bypass 
the DROSHA processing as well. 
After DROSHA cleavage, the products are transported to cytoplasm by Exportin-
5. The miRNA precursor at this step is called “pre-miRNA”. TARBP2 binds the 3’ 
overhang and recruit DICER to hairpin. DICER chops the terminal loop off and converts 
the pre-miRNA into miRNA duplex, which is subsequently bound by AGO2. 
Interestingly, not all pre-miRNAs require DICER to remove the hairpin region; pre-miR-
451 use AGO2 to remove its hairpin loop region (Cheloufi, Dos Santos et al. 2010; 
Cifuentes, Xue et al. 2010; Yang, Maurin et al. 2010). When silencing DICER, miR-451 
is the only miRNA normally processed. After DICER processing, miRNA duplex is 
loaded to AGO2. One strand of miRNA duplex will be kept in AGO2, while the other 
strand will be released. The detailed mechanism of strand selection is still not clear, but 
there is evidence showed the strand selection is determined by thermodynamics of pairing 
at both terminal of miRNA duplex. The strand kept in AGO2 is mature miRNA and has 
ability to regulate downstream targets. On the other hand, the released strand is called 
“miRNA star” (miRNA*). In general, miRNA* will be degraded, but deep-sequencing 
results showed many miRNA*s are not degraded, instead, they associate with AGO1 or 
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AGO2 and become a mature functional miRNA. These functional miRNA*s are more 
likely to be evolutionary-conserved (Okamura, Phillips et al. 2008). This finding showed 
some miRNAs are bi-functional in regulation. 
In 2006, two groups showed the evidences of post-transcriptional regulation of 
miRNA processing. Obernosterer et al. first described the mature hsa-miR-138 only 
appears in certain cell types while its precursor is ubiquitously expressed (Obernosterer, 
Leuschner et al. 2006). Additionally, they found the pre-mir-138 accumulated in the 
cytoplasm and was unable to be processed by DICER. Secondly, Thomson et al. found 
out the mature hsa-let-7 is detectable only in the late stage in mouse development, 
whereas its precursor is expressed across the entire development (Thomson, Newman et 
al. 2006). They also found the pri-let-7 were accumulated in the nucleus and unable to be 
""""""""""""""""""""""""""""""""" "
          (Krol et al. 2010) 
"
Figure 2.1 Post-transcriptional regulation of miRNA pathway. 
"
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bound and processed by DROSHA while the DROSHA activity is normal. Both works 
suggested there is a post-transcriptional mechanism that controls miRNAs maturation. 
Since then, remarkable progress has been made in identifying post-transcriptional 
biogenesis regulators, and DROSHA interacting proteins are the first targets. Two RNA 
helicases, DDX5 (p68) and DDX17 (p72), were found in DROSHA Microprocessor 
complex, and silencing DDX5 and DDX17 reduced one third of miRNAs’ expression in 
mouse (Fukuda, Yamagata et al. 2007). They interact with DROSHA to stabilize the 
interaction between miRNA precursors and DROSHA. Heterodimer, DDX5/DDX17, 
also works as scaffold proteins and recruit other regulatory proteins. For example, 
SMAD1 and SMAD3 induce the maturation of a set of miRNAs by interacting with 
DDX5 (MH2 domain) and the miRNA precursors (DNA binding MH1 domain) when the 
BMP2/TGFα signaling pathway is activated (Davis, Hilyard et al. 2008; Davis, Hilyard 
et al. 2010). The miRNAs bound by SMAD1/3 (R-Smad) contain a conserved CAGAC 
motif, called RNA Smad binding element (R-SBE). SMAD4 (the co-Smad) does not bind 
to miRNA precursor directly but is able to facilitate the binding of other SMADs (Davis, 
Hilyard et al. 2010). SMADs directly bind to this motif and promote the miRNAs 
maturation (Figure 1b). KSRP is known to interact with single-strand AU-rich mRNA 
and plays a mediator of mRNA decay. Moreover, KSRP also serves as a component of 
DROSHA and DICER complex, and it promotes the maturation a subset of miRNA in 
nucleus and cytoplasm through binding to the terminal loop of miRNA precursors. 
Interestingly, the two types of miRNA biogenesis positive regulators can be 
phosphorylated and interact with each other. In mensenchymal C2C12 cell, 
phosphorylated SMAD proteins (SMAD4, SMAD5 and SMAD9) associate with 
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phosphorylated KSRP and block their binding to target primary miRNAs (Viswanathan, 
Daley et al. 2008) (Figure 2.1).  
In MCF7 cell line, estrogen receptor alpha (ESR1) interacts with DDX5/DDX17 
upon activated by estrogen. The interaction induces dissociation of pri-miRNAs from 
microprocessor or cause conformational change of microprocessor (Yamagata, Fujiyama 
et al. 2009). Therefore, it blocks DROSHA-mediated processing to certain pri-miRNAs, 
such as hsa-mir-125a and hsa-mir-145. Another example is tumor suppressor gene TP53, 
which stimulates the biogenesis of pri-miR-16-1, pri-miR-143 and pri-miR-145 through 
DDX5-mediated interaction with DROSHA complex (Suzuki, Yamagata et al. 2009). 
TP53 is known to regulate downstream genes through transcriptional regulation, but its 
modulation to pri-miRNA is transcription-independent. 
In addition to DDX5 and DDX17, there are more proteins being pulled down 
from DROSHA-DGCR8 complex, including HNRNPH1 and HNRNPR. Immuno-
precipitation showed both HNRNPH1 and HNRNPR interact with pri-miRNA. Knocking 
down of HNRNPR increases the level of several mature miRNAs, and silencing of 
HNRNPH1 has various effects on tested mature miRNAs (Volk and Shomron 2011). 
ILF3 is another interacting protein of DGCR8, and heterodimer ILF3/ILF2 (also known 
as NF90/NF45) competes against DROSHA/DGCR8 by binding to the basal region of 
miRNA precursors in sequence independent fashion. BRCA1 is known to form a 
BRCA1-associated genome surveillance complex in order to repair DNA damage and 
prevent cell with severe DNA damage from proliferation. DHX9, a putative RNA 
helicase, carries DEAH (Asp-Glu-Ala-His) box and is able to alter RNA secondary 
structure. It has been reported to interact with DDX5, DDX17 and BRCA1. In HeLa cell, 
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BRCA1 and DHX9 were found to interact with DROSHA, SMAD3 and modulate 
miRNA maturation. RNA immunoprecipitation showed the precursors of hsa-let-7a-1, 
hsa-mir-16-1, hsa-mir-145 and hsa-mir-34a associate with BRCA1 and DHX9, and 
silencing BRCA1 or DHX9 decreases the mature level of associated miRNAs. FUS is a 
RNA-binding protein and mostly located in nucleus. It was identified in DROSHA 
complex in 2004 and was shown to participate in miRNA biogenesis recently. FUS is 
recruited to the chromatin where the miRNA is transcribed and binds the corresponding 
pri-miRNA. FUS depletion also decreases DROSHA level at the same chromatin loci, 
indicating FUS also helps to bring DROSHA to the pri-miRNA.  
Besides the proteins introduced above, there are still many proteins physically 
associate with DROSHA, such as DDX3X, HNRNPU, TDP43 and NCL. Some of them 
carry similar protein domain with known biogenesis regulators; therefore, their roles in 
miRNA biogenesis still need to be clearly investigated (Gregory, Yan et al. 2004; 
Shiohama, Sasaki et al. 2007). 
MiRNA biogenesis can be regulated independently. Some miRNAs are located in 
a cluster and being expressed together from the same nascent transcript. Cluster miR-17-
92 contains six miRNAs, and they all associate with several different cancers by targeting 
important tumor-suppressor genes. Interestingly, the miRNAs in this cluster have 
different expression profiles. The detailed biogenesis mechanism of this cluster is still 
being studied, but HNRNPA1, an alternative-splicing factor, has been identified to target 
the terminal loop region of pri-mir-18a specifically from the miR-17-92 miRNA cluster 
and promote its maturation by facilitating DROSHA-mediated processing (Michlewski, 
Guil et al. 2008).  
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The best-studied negative biogenesis regulator is LIN28, which inhibits the 
maturation of let-7 family by targeting the terminal loop of let-7 precursors and interfere 
DROSHA processing (Figure 1b) (Heo, Joo et al. 2008; Newman, Thomson et al. 2008; 
Piskounova, Viswanathan et al. 2008). Additionally, LIN28 works in the cytoplasm and 
prevents pre-let-7 from DICER cleavage. In human, there are LIN28A and LIN28B two 
homolog genes, and both of them are able to inhibit the maturation of let-7 miRNAs 
family; however, they use different mechanism to modulate maturation of let-7 
(Piskounova, Polytarchou et al. 2011). LIN28A induces post-transcriptional modification 
to let-7 precursors and block Dicer processing by adding additional nucleotides in the 
cytoplasm. On the other hand, LIN28B functions in the nucleus by targeting the terminal 
loop of pre-let-7 family and inhibit DROSHA processing. Interestingly, LIN28 is one of 
the targets of mature let-7 family, and this makes the regulation between let-7 family and 
LIN28 a double-negative feedback loop. Another special negative regulator is DROSHA 
itself, which is essential to miRNA biogenesis. DROSHA recognizes the two stem loops 
formed within DGCR8 mRNA and degrade it. Thus, the ratio of DROSHA and DGCR8 
is important for miRNA processing.  
Maturation of certain miRNAs is regulated by RNA editing. ADAR is an 
adenosine deaminase, which converts adenosine to inosine (A-to-I). RNA editing is able 
to change the hairpin structure of miRNA precursors and decrease the binding affinity of 
miRNA precursors to microprocessor (Kawahara, Zinshteyn et al. 2007; Kawahara, 
Megraw et al. 2008; Heale, Keegan et al. 2009). The A-to-I RNA editing directs miRNAs 
to Tudor-SN and enhances miRNA degradation. In addition to controlling the miRNA 
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concentration, A-to-I RNA editing expands the miRNA-targeting repertoire if the seed 
sequence of mature miRNA was edited (Kawahara, Zinshteyn et al. 2007).  
Deep-sequencing technology allows us to identify novel miRNAs and miRNAs 
with untemplated 3’ end addition. LIN28 recruits a noncanonical poly-A polymerase, 
TUT4, and adds untemplated uridine at the 3’ end of miRNA.  With extended uridine at 
the 3’ end, pre-miRNA is unable to bind TARBP2 and fail to be processed by DICER. 
This uridylyl group is able to recruit 3’ to 5’ exonuclease as well (Heo, Joo et al. 2008; 
Hagan, Piskounova et al. 2009; Heo, Joo et al. 2009; Jones, Quinton et al. 2009; 
Lehrbach, Armisen et al. 2009). Therefore, the modified and unprocessed pre-miRNAs 
are directed to degradation. The other 3’ end addition is adenylation. The deep-
sequencing data showed many mature miRNAs have additional adenine at 3’ end. The 
cytoplasmic poly-A polymerase GLD2 was found to monoadenylates and stabilizes miR-
122 in mammals (Katoh, Sakaguchi et al. 2009). This suggests 3’ end adenylation is a 
mechanism to control the concentration of miRNAs. Like protein-coding genes, the 
concentration of miRNAs is determined by the rate of expression, processing and 
degradation. In C. elegans, miRNA degradation is mediated by 5’ to 3’ exonuclease 
XRN-2, a quality control protein that removes incorrectly modified tRNA in yeast. 
Mature miRNAs bound to miRISC, and both 5’ and 3’ end of miRNA are attached and 
occupied by AGO2, which makes miRNAs resistant to degradation by exonuclease 
(Chatterjee and Grosshans 2009). Interestingly, miRNAs bind to target mRNA are 
resistant to XRN-2 as well due to occupied 3’ and 5’ end. The observation suggests target 
mRNA and miRNA modulate the degradation rate of each other. 
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MiRNAs regulate gene expression post-transcriptionally by mRNA degradation 
or translational repression. Translational repression does not affect the mRNA level but 
inhibit translation by deadenylate mRNA and interfere mRNA circulation. In 
conventional translation process, PABP1 binds poly-A tail and interacts with the cap-
initiation complex through eIF4G to make mRNA a circle. When the miRISC targets 3’ 
UTR, PABP1 dissociates from poly-A tail; meanwhile, the cytoplasmic deadenylase 
complex, including CAF1, CCR5 and CNOT1, starts to degrade poly-A tail. This process 
is for impeding the mRNA circulation; therefore, the translation initiation complex will 
not be recruited to start codon. On the other hand, the mRNA degradation starts with the 
dissociation as well, then the DCP1-DCP2 decapping complex removes 5’ cap of mRNA. 
Finally, the 5’-to-3’ exonuclease, XRN1, degrades uncapped target mRNA. Currently, it 
is still unclear that which method is mainly adopted in miRNA regulation. MiRNA-
mediated translational repression was first observed in C. elegans. However, more and 
more evidences suggested mRNA degradation is predominantly used in animal, while 
translational repression is mostly adopted in plants. When measure the protein and 
mRNA change simultaneously upon perturbing single miRNA, more than 80% of 
affected proteins have significant change in miRNA level. This implies that in animal, the 
negative correlation between miRNA and its target should be observed. 
Hundreds of miRNAs are identified in human, and each miRNA was estimated to 
regulate more than a hundred target mRNA level. Therefore, the entire miRNA-mRNA 
network comprises millions of miRNA-target interactions, and the complexity brings a 
lot of interest in developing bioinformatics approach to predict miRNA targets. Many 
tools have been developed to predict miRNA-target interactions, and these tools use the 
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knowledge in miRNA biology to design the algorithms. The knowledge include: a) The 
perfect complimentary of miRNA seed region to mRNA 3’ UTR b) The conservation of 
miRNA target site c) The secondary structure of mRNA d) The expression profile of 
mRNA and miRNA e) Number of miRNA target sites. Among all the tools, Targetscan is 
the most widely used miRNA target prediction tool. Besides the perfect complimentary 
of seed region and the conservation of predicted miRNA binding sites, Targetscan built 
context score for each predicted miRNA binding site. The context scores are determined 
by the location and the type of binding sites. There are four types of miRNA target sites: 
8mer means the miRNA 1st to 8th nucleotides are perfectly match (Watson-Crick pairing) 
to the binding sites, or the 1st nucleotide mismatch to an Adenosine on 3’ UTR. 7mer-m8 
means the 2nd to 8th nucleotides match to the binding site. 7mer-A1 means the 2nd to 7th 
nucleotides match to the binding site with 1st nucleotide mismatching to Adenosine. 
These three types of sites are considered as “canonical” target sites. Six-mer means only 
the 2nd to 7th nucleotides matched to 3’ UTR, and this type of sites are considered as 
“noncanonical”. The site efficacy is determined by quantification from microarray data 
and the hierarchy is as follows: 8mer >> 7mer-m8 > 7mer-A1 >> 6mer > no site, with the 
6mer differing only slightly from no site at all. The location of miRNA target sites also 
affects the miRNA efficiency: the target sites closer to both end of 3’ UTR generally 
have higher efficiency than the sites in the middle. These two features comprise of the 
context scores of miRNA target sites in Targetscan. The other more common miRNA 
target prediction tools include PITA, miRanda, PicTar, RNA22. All of them follow 
similar guidelines to infer miRNA targets with different approaches. For example, PITA 
also considered the accessibility of miRNA target sites from the secondary structure of 
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3’UTR. However, all prediction tools still have room to improve their performance. The 
poor performance may not due to the design of algorithm but because our current 
understanding to miRNA biology is not thorough enough. Additional proteins may be 
involved in the miRNA-mediated regulation and need to be considered. Different 
contexts also have distinct miRNA targeting profiles, thus building context-specific 
miRNA target prediction is necessary to have a full understanding of miRNA regulation. 
Several proteins are known to modulate miRNA-targeting mechanism described 
above. For example, FMRP and PUF are positive modulators that bind miRISC and 
stabilize the interaction between miRISC and miRNA (Nolde, Saka et al. 2007; Galgano, 
Forrer et al. 2008; Edbauer, Neilson et al. 2010). Negative modulators, such as DND1 
and ELAVL1, interfere miRNA targeting by displacing miRISC from the miRNA 
binding site or competing against miRISC for the same binding site on the 3’ UTR 
(Bhattacharyya, Habermacher et al. 2006; Mishima, Giraldez et al. 2006; Kedde, Strasser 
et al. 2007). Along with the invention of high-throughput technology, we can measure the 
RNA-protein interaction happened in the whole biological system. RIP-chip uses 
microarray to measure the endogenous mRNAs bound by protein and get the binding 
motif from the target mRNAs. 
Currently, several techniques have been used to systematically identify 
endogenous miRNA-target interactions. Microarray and SILAC (stable isotope labeling 
by amino acids in cell culture) profile the entire transcriptome and proteome (Baek, 
Villen et al. 2008; Selbach, Schwanhäusser et al. 2008). Both methods were applied to 
detect miRNA targets after perturbing the expression of single miRNA. Complementary 
sequence of miRNA seed region is enriched in the 3’UTR of affected mRNA and protein, 
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suggesting the affected mRNAs and proteins are targeted by miRNA. The concern of 
using microarray and SILAC to validate miRNA targets is the differentially expressed 
mRNAs or proteins may not be directly targeted by tested miRNA, since the miRNA 
seed region is only seven-bases long and easy to find complementary sequence on 3’UTR. 
HITS-CLIP (High-throughput sequencing of RNA isolated by crosslinking 
immunoprecipitation) and PAR-CLIP (Photoactivatable-ribonucleoside-enhanced 
crosslinking and immunoprecipitation), both technologies use ultraviolet cross-linking to 
fix the interactions between RNA and protein and obtain the actual binding sites using 
next generation sequencing. In the first PAR-CLIP work, the binding sites of PUM1, QKI, 
AGO2, IGF2BP1, IGF2BP2, IGF2BP3, TNRC6A, TNRC6B, TNRC6C and ELAVL1 
have been detected by this high-throughput method in HEK293 cell (Chi, Zang et al. 
2009; Hafner, Landthaler et al. 2010; Lebedeva, Jens et al. 2011; Mukherjee, Corcoran et 
al. 2011). Many of the binding sites were found to overlap with potential miRNA binding 
sites, which indicates they also modulate miRNA activity and interfere the miRNA 
regulation by competing the same binding sites. PAR-CLIP of AGO2 and RNA revealed  
In the HITS-CLIP work, Chi et al. performed cross-linking between AGO and 
RNA in mouse brain in order to detect endogenous AGO-RNA interactions. Two 
different molecular weights (~110 kD and ~130 kD) of radiolabeled protein-RNA 
complexes were detected using autoradiogram, suggesting AGO is crosslinked to two 
different types of RNA. RT-PCR revealed the 110 kD complex harbored short RNA 
around 22 bases and the 130 kD complex contained both longer and 22-base short RNA. 
The associated RNAs were then identified using next generation sequencing. In summary, 
over 60% AGO binding sites locate in 3’UTR and the most enriched miRNA and miRNA 
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binding site are mouse-specific miRNA, miR-124. The identified binding sites of miR-
124 were further validated for evolutionary conservation and luciferase reporter assay. 
This high-throughput method was shown to successfully complement the bioinformatics 
approaches to identifying miRNA target sites only from AGO-crosslinked region (Chi, 
Zang et al. 2009). 
Crosslinking, Ligation And Sequencing of Hybrids (CLASH) is the latest 
developed method to identify miRNA-target interaction (Helwak, Kudla et al. 2013). The 
miRNA-target duplexes associated with human AGO1 were cross-linked by ultraviolet 
and pulled down. After RNA fragmentation, ligation of miRNA and miRNA binding site, 
cDNA synthesis and sequencing of AGO1-associated RNAs, the miRNAs and their 
targets can be detected in one single chimeric read. This method found many 
overrepresented motifs on chimeric reads that are complementary to miRNA seed region 
as expected. However, some overrepresented motif associated with miRNAs is 
complementary to the middle or 3’ end of miRNA instead of seed region. Moreover, the 
association between the results of HITS-CLIP, PAR-CLIP, CLASH and the predictions 
from TargetScan and Miranda is not significant. Only around 37% of CLASH results 
showed uninterrupted Watson-Crick pairing in seed region. CLASH also revealed many 
detected miRNA binding sites that are located in coding region. Over 70% of miR-149 
binding sites fall in coding region while only 19% in 3’UTR. HITS-CLIP and PAR-CLIP 
also showed 37% and 50% of AGO binding sites are in coding region. All bioinformatics 
efforts to identify miRNA targets were built on the concepts of finding complementary 
sequence of seed region in 3’UTR, but the concept may not fully reflect the real 
mechanism of miRNA-mediated regulation. Such events may be due to non-specific 
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binding of AGO2 or noises generated from these new technologies, but it also suggests 
we still need to put many efforts to improve our understanding of miRNA targeting 
mechanism besides seed sequence recognition (Chi, Zang et al. 2009; Helwak, Kudla et 
al. 2013). 
MiRNAs are known to participate in various biological pathways and diseases. 
Certain miRNAs are called oncomiRs or tumor suppressor miRNAs by targeting 
important tumor suppressor genes or oncogenes. Dysregulation of these miRNAs, 
consequently, were identified in most solid tumors and hematological malignancies. In 
GBM, miRNAs that participate in the tumorigenesis include miR-21, miR-26a, miR-221, 
miR-222 and miR-7. MiR-21 is one of the most highly expressed miRNA in GBM 
patient. It targets DAXX, TP53BP2, and HNRNPK to down-regulate TP53 
(Papagiannakopoulos, Shapiro et al. 2008). MiR-21 also targets and suppresses tumor 
suppressor PDCD4 (Chen, Liu et al. 2008). This protein inhibits the initiation of 
translation and promotes cell cycle arrest via P21. PTEN is a crucial tumor suppressor 
gene and frequently found deleted in GBM patients. In addition, miR-26a has been 
identified to target PTEN in GBM context (Huse, Brennan et al. 2009). It is the only 
focally amplified miRNA at DNA level in TCGA GBM patients and mostly in 
association with monoallelic PTEN deletion. MiR-221 and miR-222 are both up-
regulated in GBM, and they share the same targets due to the identical seed regions. They 
regulate various important targets, such as p27, PUMA, p57 and PTPµ (Lu, Zhao et al. 
2009; Zhang, Zhang et al. 2010; Zhang, Han et al. 2010; Quintavalle, Garofalo et al. 
2012). In glioma, miR-221 and miR-222 have cooperative effect to activate AKT 
pathway and promote malignant progression. They also target PUMA to induce glioma 
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cell proliferation. Overexpression of miR-221/222 induces glioma cell proliferation and 
invasion in vitro and glioma growth in subcutaneous mouse model. MiR-7 is a potential 
tumor suppressor miRNA, but it is often found down-regulated in GBM. EGFR/AKT 
pathway is important in developing primary GBM. The pathway downstream effects are 
inhibition of apoptosis, proliferation and growth. It is found that 60% of GBM patients 
carry EGFR amplification. MiR-7 targets EGFR and inhibits the downstream AKT 
pathway (Kefas, Godlewski et al. 2008). The expression level of pri-mir-7 is equal 
between normal brain and GBM tissue; therefore the down-regulation of miR-7 in GBM 




Identification of miRNA promoters 
3.1 Introduction 
MiRNAs are key post-transcriptional regulators but their promoters and 
transcription start sites are poorly characterized. It is difficult to identified miRNAs 
promoter is mainly because of the short half-life of miRNA precursors and different 
miRNA biogenesis mechanisms. Currently, miRBase records 1872 human miRNA genes, 
but only the sequences of hairpin structure are documented. In our analysis, our strategy 
is to identify miRNA post-transcriptional regulators using intragenic miRNAs and their 
host mRNAs. Additionally, we included the miRNAs located in the same transcriptional 
unit and regard one of the miRNAs as host mRNA. To use intragenic miRNAs, the first 
work is to test if the intragenic miRNAs or clustered miRNAs are transcribed from the 
same transcription unit. 
Transcriptionally active promoters and transcription start sites possess some 
special features, including nucleosome depletion around the transcription start sites, tri-
methylation on Histone 3 Lysine 4 residue (H3K4me3) and acetylation on Histone 3 
Lysine 9, Lysine 14 and Lysine 27 (H3K9ac, H3K14ac and H3K27ac) around active 
promoters and transcription start sites. Several methods have been developed based on 
these features to identify promoters, including nucleosome mapping and ChIP (chromatin 
immunoprecipitation) assay of histone modifications (Kodzius, Kojima et al. 2006; Ernst, 
Kheradpour et al. 2011). CAGE (Cap Analysis Gene Expression) sequencing is a new 
method derived on the basis of mRNA processing (Kodzius, Kojima et al. 2006). This 
method captures the capped 5’ end of processed full-length mRNAs and identifies 
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transcription start sites on a genome-wide scale. To carry out CAGE, biotin bead was 
firstly conjugated to capped 5’ end of mRNA and perform reverse transcription using 
random primers. Then use RNAase to degrade single strand RNA and pull down biotin-
modified RNA-cDNA duplex using streptavidin. Finally, denature the RNA-cDNA 
duplex and sequence the cDNA. This method detects the precise location of 5’ end of 
mRNA and provides the direct evidence of transcription start sites.  
Ozsolak et al. firstly applied nucleosome mapping and and ChIP-chip of 
chromatin signature (H3K4me3, H3K9ac, H3K14ac, RNA polymerase II/III) in MALME, 
UACC62 and MCF7 cell lines to identify miRNA promoters (Ozsolak, Poling et al. 
2008). They identified the promoter region of 175 miRNAs expressed in these three cell 
lines. Furthermore, they observed one third of intronic miRNAs have promoters 
independent from the their host genes. 
This chapter summarizes the work of using the annotation of ChIP-seq from 
ENCODE (Encyclopedia of DNA Elements) and CAGE-seq from FANTOM (Functional 
Annotation of the Mammalian Genome) to identify intragenic miRNA promoters (Kawaji, 
Severin et al. 2011; Consortium, Bernstein et al. 2012). The two data sets provide 
comprehensive coverage of different contexts and conditions, including various tissues 
and cell lines with different treatments and time points. 
3.2 Material and Methods 
Chromatin modifications have been used to annotate genome sequences and 
detect cis-regulatory elements, given the important role of chromatin in DNA 
accessibility and recruitment of regulatory elements. ENCODE provides ChIP-seq data 
for eight histone modifications and one insulator protein (CTCF) from nice human cell 
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lines. The cell lines used in this study consist of embryonic stem cells (H1 ES), 
erythrocytic leukemia cells (K562), B-lymphoblastoid cells (GM12878), hepatocellular 
carcinoma cells (HepG2), umbilical vein endothelial cells (HUVEC), skeletal muscle 
myoblasts (HSMM), normal lung fibroblasts (NHLF), normal epidermal keratinocytes 
(NHEK) and mammary epithelial cells (HMEC). The ChIP-seq provided by ENCODE 
include: H3K4me3, H3K4me2, H3K4me1, H3K9ac, H3K27ac, H3K36me3, H4K20me1, 
H3K27me3 and CTCF. CTCF recognizes CCGCGNGGNGGCAG motif and its binding 
blocks the interaction between promoter and enhancers; therefore, CTCF binding was 
used to identify insulators.  
ENCODE consortium then applied multivariate Hidden Markov model that uses 
combinatorial of chromatin modifications to infer chromatin states, and the algorithm is 
called “chromHMM”. Fourteen distinct transcriptional states were summarized from 
ENCODE ChIP-seq data. The transcriptional states include active/weak/inactive 
promoter, strong/weak enhancer, insulator, transcriptional transition/elongation, weak 
transcribed, polycomb repressed, heterochromatin and repetitive region. 
The other data set used in this analysis is CAGE-seq from FANTOM. The 
FANTOM consortium conducted CAGE-seq for 1065 samples from different tissues and 
human cell lines under different treatment and time points. Previous study showed 
intragenic miRNAs that carry independent promoters are able to co-expressed with host 
mRNA in certain contexts. Therefore, this comprehensive data set provides us a broad 
coverage of the transcriptional landscape of intragenic miRNAs. Additionally, CAGE-seq 
provides direct evidence of transcription start sites compared to other methods. Note the 
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CAGE-seq is not public available yet at the time when this thesis is being prepared. It 
will be available when the pilot paper of FANTOM5 is published. 
3.3 Results 
Based on miRBase v18 and RefSeq hg19 annotation, 697 out of 1523 human 
miRNAs locate in 621 host genes. Due to every project adopts different miRNA 
expression platform, the numbers of host-miRNA pairs in each dataset varies. For 
example, there are 470 miRNA expression profiles and 226 host-miRNA pairs in GBM 
data but 723 miRNA expression profiles and 350 host-miRNA pairs in OV data. To 
determine miRNA clusters, the criteria for miRNAs to be in the same transcription unit 
are: 1) the miRNAs on the same strand of chromosome. 2) The miRNAs are within a 
10kb. 3) The miRNAs have significant correlated expression profiles. 4) No other 
annotated transcript located in between. 5) No active promoter region was detected by 
chromHMM between the miRNAs. We identified 89 miRNA clusters, ranging from two 
miRNAs to 46 miRNAs. 
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To identify the independent promoter of intragenic miRNA, the interval region 
between transcription start sites of host mRNA and 5’ end of miRNA precursor was 
examined. We obtained the chromHMM annotation for nine human cell lines and 
examine the existence of active promoters in the interval region. On the other hand, the 
sequence reads of CAGE-seq data from every sample was normalized into RPM (reads 
per million reads). Similarly, we examined the existence of sequencing reads from CAGE 
in the interval region to identify the promoters of intragenic miRNAs. 
""""""""""""""""""""""""""""""""""""""""""" "




From the chromHMM annotation, 59 intragenic miRNAs have potential to be 
transcribed independently in the nine human cell lines (Table 3.1). From FANTOM 
CAGE-seq, 42 intragenic miRNAs have CAGE-seq between transcriptional start sites 
(Table 3.2). Notably, none of the intragenic miRNAs with independent promoter have 
                              
Table 3.2 Intragenic miRNAs with CAGE-seq reads in FANTOM. The listed reads 
are normalized RPM (reads per million). The “Max Reads” represents the number of 
max RPM from single sample, and the “Total Reads” represents the sum of RPM from 
all 1065 samples in FANTOM. 
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CAGE-seq reads in all samples. This circumstance may be due to the intragenic miRNAs 
are not ubiquitously expressed in all contexts. Another explanation is that they can adopt 
the promoter of host genes in certain conditions. 
An example of intragenic miRNA possessing independent promoter: miR-21 is 
the most well studied oncomiR, and it is only around 700 bases away from its 
neighboring gene, VMP1. In some annotation, miR-21 was annotated in the same 
transcription unit as VMP1. Here, CAGE-seq data and chromHMM both indicates miR-
21 possesses its promoter (Figure 3.1). Another example is miR-9. Mir-9-1 resides in the 
second intron of C1orf61. The CAGE-seq and ChIP-seq of H3K4me3 clearly showed 
miR-9-1 possesses its own promoter, and it can be expressed independently. The data 
also showed even if the miRNA possesses its own promoter, it can still be co-transcribed 
with its host gene in certain contexts (Figure 3.2). 
"
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Figure 3.1 miR-21 possesses its own promoter. CAGE-seq and chromHMM showed 





In this chapter, we summarized the results from chromHMM and CAGE-seq to 
identify the intragenic miRNAs with independent promoters. After selecting miRNAs 
that are co-transcribed with host genes, we examine the relationship between the host 
mRNA and the intragenic miRNA in glioblastoma multiforme (GBM), ovarian serous 
cystadenocarcinoma (OV), acute myeloid leukemia (AML), breast invasive carcinoma 
(BRCA) from TCGA, and prostate adenocarcinoma (PRAD) from GSE21032 using 
spearman correlation (Figure 3.3). Although these intragenic miRNAs co-transcribe with 
their host genes, the relationships between some host-miRNA pairs are still not 
significant or even anti-correlated, indicating miRNA biogenesis pathway is indeed 
extensively controlled by post-transcriptional regulators.  
"
Figure 3.2 let-7g is co-transcribed with host and miR-9 expresses independently. 
CAGE-seq and ChIP-seq of H3K4me3 showed let-7g is co-transcribed with its host 
gene, while miR-9-1 possesses an independent promoter. Notably, CAGE-seq showed 
miR-9-1 is co-transcribed with its host, C1orf61 in certain conditions. 
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Oh the other hand, the distribution of spearman correlation between miRNAs in 
the same cluster also showed that clustered miRNAs might undergo separate regulation in 
the maturation process (Figure 3.4). Indeed, we observed the same scenario from small 
RNA sequencing for RNA between 50 and 150 bases and shorter than 30 bases in SNB19 
cells. MiR-17, miR-18a and miR-19a are in the same transcription unit, miR-17-92 
cluster, and they are 376 bases apart. However, only miR-17 and miR-19a were 
successfully being processed into mature miRNAs. The maturation of miR-18a was 
stalled by post-transcriptional regulation; therefore, pri-miR-18a was accumulated in 
SNB19 cell (Figure 3.5). 
In summary, we have collected around 250 host and miRNA pairs by using 
chromHMM in ENCODE and CAGE-seq in FANTOM. The next step is to take 
advantage of these host-miRNA pairs and perform genome-wide scanning for regulators 






Figure 3.3 Histograms of spearman correlation between host mRNAs and 





Figure 3.4 Histograms of spearman correlation between two miRNAs in the same 




Figure 3.5 Small RNA deep-sequencing showed miR-18a level was regulated by 
distinct post-transcriptional mechanism in SNB19 cell. 
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Chapter IV 
Identification of miRNA biogenesis regulators 
4.1 Introduction 
Tumor-specific aberrant expression of microRNAs (miRNAs) contributes to 
many cancer types, and the dysregulation of their post-transcriptional biogenesis 
regulators have been repeatedly seen in cancer (van Kouwenhove, Kedde et al. 2011) and 
is known to affect tumor growth. Particularly, the inactivation of DROSHA, DICER and 
other members of the microprocessing complexes, the canonical miRNA biogenesis 
regulators, is known to affect both development (Han, Lee et al. 2006; Suzuki, Yamagata 
et al. 2009; Melo, Moutinho et al. 2010; Franceschini, Szklarczyk et al. 2013) and 
carcinogenesis (Viswanathan, Daley et al. 2008), including gliomagenesis (Yamagata, 
Fujiyama et al. 2009; Ernst, Campos et al. 2010), breast cancer survival (Dews, Fox et al. 
2010), and ovarian cancer progression and prognosis (Malzkorn, Wolter et al. 2010; Rao, 
Santosh et al. 2010; Lages, Guttin et al. 2011) through miRNA-dependent and miRNA-
independent pathways (Wuchty, Arjona et al. 2011). For example, TARBP2 is a vital 
component of the DICER processing complex (Glesne and Huberman 2006), and 
Exportin 5 (XPO5) transports pre-miRNAs to the cytoplasm. Down regulation of either 
protein depresses the expression of mature miRNAs and promotes tumorigenesis 
(Friedman, Farh et al. 2009; Melo, Ropero et al. 2009; Melo, Moutinho et al. 2010). 
While perturbations to canonical miRNA biogenesis regulators affect 
pathophysiologically relevant processes in the cell, it does not account for all tumor 
specific expression of miRNAs (Lu, Getz et al. 2005). 
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Non-canonical regulators of miRNA biogenesis target mature miRNAs and/or 
their precursors with sequence and structure bias (Grimson, Farh et al. 2007; Yi, Pasolli 
et al. 2009; Volk and Shomron 2011). Among all identified non-canonical miRNA 
biogenesis regulators, LIN28 is one of the best-studied regulators (Zhang, Zhang et al. 
2010; Piskounova, Polytarchou et al. 2011). It recognizes the motif on the hairpin loop of 
let-7 family miRNAs and represses their processing. Over-expression of the oncogene 
LIN28B is known to increase tumor proliferation by suppressing the biogenesis of the 
tumor suppressor let-7. Moreover, deleterious SNPs at its locus influence susceptibility to 
epithelial ovarian cancer (Zhang, Han et al. 2010), leukemia (Medina, Zaidi et al. 2008; 
Lu, Zhao et al. 2009), breast cancer (Quintavalle, Garofalo et al. 2012) and other 
malignancies (Thornton and Gregory 2012). Other well-known examples are the dead-
box RNA helicases DDX5 and DDX17 (Fukuda, Yamagata et al. 2007; Paris, Ferraro et 
al. 2012). DDX5 and DDX17 form a complex with DROSHA and DGCR8, and interact 
with DHX9 (Kawai and Amano 2012) to promote miRNA maturation. The oncogenic 
receptor-regulated SMAD proteins, SMAD1, SMAD3 and SMAD5, have been shown to 
regulate miRNA-biogenesis regulation by controlling DROSHA-mediated miRNA 
maturation through interaction with DDX5 and miRNA precursors in response to TGFβ 
and BMP signaling (Davis, Hilyard et al. 2008). Recently, another study showed SMAD4, 
SMAD5 and SMAD9 can associate with phosphorylated KSRP and block its interaction 
with primary myogenic miRNAs (Pasero, Giovarelli et al. 2012). The interaction 
abrogates the KSRP-dependent miRNA maturation on let-7 and, therefore, affects cell 
differentiation (Viswanathan, Daley et al. 2008; Trabucchi, Briata et al. 2009; Pasero, 
Giovarelli et al. 2012). HNRNP complex modifies pre-mRNA processing, stability and 
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transport post-transcriptionally, and some subunits in HNRNP complex are directly 
involved in miRNA processing as well. HNRNPA1, HNRNPH1 and HNRNPR are able 
to interact with pri-miRNA and DGCR8 complex. HNRNAPA1 and HNRNPR have 
inhibitory effects on several mature miRNAs, while HNRNPH1 promotes miRNA 
processing. In total, over a dozen non-canonical miRNA biogenesis regulators have been 
identified (Grimson, Farh et al. 2007), and many of these have already been associated 
with pathogenesis and tumorigenesis. Their full repertoire, including their tissue and 
tumor specific activities remains unknown and the focus of extensive research for nearly 
"
Figure 4.1 The canonical miRNA biogenesis pathway.  
The miRNAs are transcribed and then being processed into pri-miRNA, pre-miRNA 
and miRNA-miRNA* duplex and mature miRNA. The core components in this 
pathway are DROSHA, XPO5, DICER1 and AGO2 
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a decade (Bartel 2004).  
The regulatory role of miRNAs in gliomagenesis has been extensively studied, 
and numerous miRNA species have been associated with glioma and its subtypes (Singh, 
Soon et al. 2012; Moller, Rasmussen et al. 2013). These glioma-related miRNAs include 
the viability and proliferation regulators miR-7 (Kefas, Godlewski et al. 2008) and miR-
34a (Li, Guessous et al. 2009), the oncogenic cluster miR-17-9 (Dews, Fox et al. 2010; 
Ernst, Campos et al. 2010) the PTEN inhibitor miR-26a (Huse, Brennan et al. 2009), and 
the neuromesenchymal-specific regulators miR-27b (Chen, Li et al. 2011) and miR-9 
(Kim, Huang et al. 2011; Schraivogel, Weinmann et al. 2011). Recent systems biology 
approaches have identified numerous miRNAs that are differentially expressed in glioma 
subtypes and are predicted to regulate gene expression in glioma (Sumazin, Yang et al. 
2011; Setty, Helmy et al. 2012) and its precursor-associated subclasses (Kim, Huang et al. 
2011). In total, over 100 miRNA species are differentially (p<1e-03 by t-test) regulated 
across glioblastoma subclasses (Lambertz, Nittner et al. 2010; Kim, Huang et al. 2011). 
While the aberrant expression of some miRNAs, including miR-26a (Huse, Brennan et al. 
2009), may be linked to the copy number variation at their loci, in 80% of the instances 
where miRNAs are aberrantly expressed their loci have no significant (aCGH ratio below 
-0.25 or above 0.25) copy number variations (Lambertz, Nittner et al. 2010). In these 
instances, aberrant expression of miRNAs is either due to transcriptional dysregulation or 
to the dysregulation of their biogenesis and decay. We set out to identify RNA binding 
proteins (RBPs) that post-transcriptionally influence the abundance of mature miRNAs in 
glioblastoma, thus accounting for some of their tumor specific expression. We report on a 
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genome-wide screen for such RBPs using TCGA expression of genes and miRNAs in 
glioblastoma tumors (Lambertz, Nittner et al. 2010). 
Our results suggest that dozens of RBPs post-transcriptionally regulate miRNA 
biogenesis. Specifically, our computational screen identified thirty-three miRNA 
regulators in glioblastoma that target both intragenic and intragenic miRNAs, of which 
eight have been previously shown to regulate miRNA biogenesis. Selecting uniformly 
across the list we validated seven predictions, including regulators that are expressed in 
tumor specific manner. For these seven RBPs, we biochemically identified miRNA 
targets in a glioblastoma cell line using qRT-PCR and Wafergen technologies. DDX10 
depletion in glioblastoma tumors downregulated the biogenesis of miRNAs, including 
miR-218, miR-18a and miR-25, while SMAD6 siRNA-mediated silencing lead to down 
regulation of mature miRNAs, including miR-196a and miR-25. Finally, we showed that 
over expression of IGF2BP3, whose locus is amplified in 40% of TCGA glioblastoma 
patients, up regulates the abundance of oncogenic miRNAs including miR-7, miR-9, 
miR-26a, miR-19a, miR-17 and miR-16 and is predictive of patient survival rates. 
MiRNAs that were downregulated as a result of siRNA-mediated silencing of IGF2BP3 
are enriched for PTEN-regulators, and IGF2BP3 silencing lead to (1) upregulation of 
PTEN 3’-UTR activity, (2) DICER-dependent upregulation of PTEN mRNA expression, 
and (3) reduction in glioma cell line growth rate. 
The Cancer Genome Atlas (TCGA) is initiated by National Cancer Institute (NCI) 
and National Human Genome Research Institute (NHGRI) in 2006. TCGA build a 
national network of research and technology teams to generate and pool data from 
multiple cancer types. The multi-dimensional data of TCGA include gene, exon and 
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miRNA expression profile, copy number, DNA methylation, somatic mutation, single 
nucleotide polymorphism and clinical information about patients. Multiple data types 
enable scientists and clinicians to approach cancer genomics from various perspectives. 
Currently, the project collects data from 20 different types of cancer, including 
glioblastoma multiforme (GBM). We utilized the TCGA GBM dataset, which consists 
gene and miRNA expression profiles from 493 patients. 
Glioblastoma is a highly aggressive and essentially incurable tumor. By 
integrating various types of high-throughput data, the TCGA dataset can be classified 
into 4 subtypes: proneural, neural, classical and mesenchymal (Verhaak, Hoadley et al. 
2010). Expression and genetic aberrations of EGFR, NF1 and PDGFRA/IDH1 define the 
classical, mesenchymal, and proneural subtypes, respectively. The gene expression 
profile in proneural is significantly different from mesenchymal. Additionally, the 
responses to chemotherapy are different between subtypes: classical and mesenchymal 
patients are sensitive to intensive chemotherapy and radiation. The mesenchymal subtype 
is associated with a state of uncontrolled ability to invade and stimulate angiogenesis to 
metastasize. The patients in mesenchymal subtype have the shortest survival span among 
all subtypes. The mesenchymal gene expression signature (MGES) is the gene set that is 
up-regulated in the mesenchymal subtype. The mechanism that controls MGES is still 
unclear. Previously, Califano lab developed ARACNe to identify the relationship 
between transcription factor and target genes using mutual information (Carro, Lim et al. 
2010). Carro et al. used ARACNe to identify the master regulators that control the MGES, 
including RUNX1, STAT3, CEBPB/D, FOSL2 and BHLHB2 as positive master 
modulators and ZNF238 as negative master modulator for MGES.  
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In 2010, Noushmehr et al. utilized DNA methylation profile in the promoter 
region to identify another distinct subgroup in the TCGA context (Noushmehr, 
Weisenberger et al. 2010). A large number of loci were identified to be hypermethylated 
in a subgroup of proneural patients, and the hypermethylation in the promoter regions 
leads to down-regulation of gene expression. This subtype is called glioma-CpG island 
methylator phenotype (G-CIMP). The characteristics of G-CIMP patients are younger at 
diagnosis and significantly improved survival span compared to the rest of proneural 
patients. Generally, G-CIMP subtype is associated with low-grade glioma and indicates 
good prognosis after intensive treatment. At molecular level, G-CIMP subtype is closely 
associated with IDH1 mutation or copy number alteration.  
MiRNA expression profile has been utilized to classify different tumors and trace 
the cell origins the tissue successfully. In TCGA GBM context, people used (i) miRNAs 
with higher variability (median absolute deviation or MAD > 0.1) (ii) miRNAs that are 
patient survival-related (significant in univariate Cox model) (iii) miRNAs that are 
neurodevelopment-related obtained from literatures to identify subtypes in glioblastoma. 
MiRNA expression profile classified TCGA GBM patients into five subtypes: 
oligoneural, neural, radial glial, neuralmesenchymal and astrocytic. Compared to the 
classification obtained from gene expression profile, oligoneural approximately 
corresponds to proneural and astrocytic corresponds to mesenchymal. The major 
difference between miRNA- and gene-defined glioblastoma subtypes is that the survival 
spans of patients after diagnosed are significantly different. Patients in oligoneural 
subtype has significantly longer survival span than patients in astrocytic subtype, while 
there is no difference between patients in proneural and mesenchymal subtypes. The 
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responses to radiation (at least 54 Gy) and 2 or more cycles of temozolomide treatment 
are clearly different as well. Astrocytic subtype is the only subtype sensitive to intensive 
treatment, while it is the most aggressive subtype as well (Kim, Huang et al. 2011). 
In this study, we applied information theory to infer the genes that are involved in 
miRNA processing network, including the post-transcriptional regulators and interacting 
proteins. Information theory is developed by Claude Shannon in 1940s’ and has widely 
been applied to a variety of field, such as statistical inference, natural language 
processing, quantum computing and systems biology. Mutual information is one of the 
important concepts in information theory. Mutual information is a measurement of the 
mutual dependence between two random variables. It showed the amount of information 
we can obtain for one random variable given the other variable. The mutual information 
between two variable X and Y can expressed as: 
! !;! = ! !;! = ! ! + ! ! − !(!,!) 
Where H(X) represents the entropy of discrete random variable X. Shannon 
entropy is a measurement in information theory, measuring the amount of uncertainty 
associated with the variable X. The entropy of X can be written as: 
! ! = − ! !! !"#! ! !! !!(!"#$%#&"&'!!"#$"%&')
! ! = − ! !!
!
!"#! ! !! !(!"#$%&'&!!"#$"%&')
 
Conditional mutual information is another measurement in information theory to 
capture three-way relationship. It showed the amount of mutual information we can 
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obtain between two random variables given the third variable. The conditional mutual 
information of variable X and Y given Z can be written as: 
! !;! ! = ! !,! + ! !,! − !(!,!,!) 
Since 1953, information theory has been regarded as a tool to study biology 
(Quastler 1953). It was used to finding splicing sites in mRNA precursors, locating 
protein-binding sites and building phylogenetic trees. Information theory has been 
successfully applied in systems biology as well. ARACNe (Algorithm for the 
reconstruction of accurate cellular networks) predicts the targets of transcription factors 
and build transcriptional network using information theoretic approach (Margolin, 
Nemenman et al. 2006; Margolin, Wang et al. 2006). It identifies the transcription factors 
and their targets with significant mutual information, and it also implements another 
concept in information theory, Data Processing inequality (DPI) to remove inferred 
""""""""""""""""""""""""""" "(Wang"2009)"
Fig 4.2 Concept of MINDy algorithm.  
Delta mutual information was used to identify candidate modulator genes 
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relationships that may be mediated by intermediate TF. The first work of ARACNe 
successfully builds the transcriptional network in B cell context.  
MINDy (Modulator inference by network dynamics) is designed to infer post-
translational regulatory network. Signaling proteins, such as kinases, phosphatases, can 
modulate the activity of transcription factors by post-translational modification. The 
three-way relationship between TF, target and signaling protein can be inferred by 
MINDy using delta mutual information. The idea is to measure the difference of mutual 
information between TF and target when candidate modulator is differentially expressed 
(Wang, Saito et al. 2009). In the first MINDy work, several novel modulators of MYC 
"
"
Figure 4.3 Concept of MIRAGE.  
(A) Candidate miRNA biogenesis regulators are predicted using intragenic and clustered 
miRNAs. 
(B) SLIT3 and miR-218 are correlated when DDX10 is highly expressed; suggesting 




activity were inferred, such as STK38, and successfully validated in human B 
lymphocytes. 
In this analysis, we developed an algorithm, MIRAGE, to identify miRNA 
biogenesis regulators. To identify miRNA biogenesis regulators, we first summarized 
intragenic miRNAs and host genes, or miRNA clusters with genomic coordinates, 
expression profiles and additional evidences (described in previous chapter). Secondly, 
MIRAGE predicted candidate biogenesis regulators by finding genes whose expression is 
correlated with deviation in co-expression between miRNA and host using conditional 
mutual information. The candidate genes from all host-miRNA pairs were integrated by 
Fisher’s method (Fisher 1925). Finally, we validate several candidate biogenesis 
regulators using siRNA silencing or over-expression. The miRNA expression level was 
then measured by real-time PCR or array-based technology, such qRT-PCR, WaferGen 
and Fluidigm. 
4.2 Material and Methods 
Estimation of mutual information and conditional mutual information 
Mutual information in this study was estimated by Gaussian kernel estimator for 
computational efficiency. The pairwise mutual information is estimated as: 
! !;! = ! !,! log!( !(!,!)! ! !(!))!" !" 
And the 1-dimensional and 2-dimensional Gaussian kernel density estimator, f(x) 
and f(x,y) are defined as: 
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The parameter N in the equations above is the number of sample used in the 
estimation, and the parameter h is smoothing parameter or bandwidth. 
On the other hand, conditional mutual information can be defined as: 
! !;! ! = !(!,!, !) log!( !(!,!, !)! !, ! !(!, !))!" !" 
The statistical significance of mutual information and conditional mutual 
information were determined by null distribution built using shuffling the expression 
profile of candidate genes. The expression profile of host mRNA and intragenic miRNA 
were hold constantly. The cutoff of conditional mutual information is less than 0.01 after 
Bonferroni correction. 
Data source 
Gene and miRNA expression was obtained from TCGA glioblastoma multiforme 
data portal. Gene and miRNA expression from glioblastoma patients were profiled on 
Agilent 244K whole genome expression array and miRNA_8x15K human specific 
microarray, respectively. Gene expression profile was Lowess normalized and the ratio of 
Cy5 (sample) to Cy3 (reference) was log2 transformed to create gene expression values 
for 18624 genes. MiRNA expression profile was quantile normalized on the probe level. 
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Signals form the probes designed to measure the same miRNA were summed together 
and log2 transformed in order to obtain miRNA-centered value (Lambertz, Nittner et al. 
2010). 
List of RNA binding proteins were obtained from Gene ontology. The protein-
protein interactions were acquired from StringDB and PrePPI (Franceschini, Szklarczyk 
et al. 2013; Zhang, Petrey et al. 2013). 
Screening for miRNA regulator 
A post-transcriptional miRNA regulator (R) is able to explain the disagreement 
between host mRNA and the miRNA in the same transcription unit. Similar with MINDY 
and Hermes, we use conditional mutual information (CMI), I(miRNA;Host|R), to identify 
post-transcriptional miRNA regulators. The statistical significance (p-value) of CMI is 
evaluated by permutation testing. All selected triplets have significant CMI (p-value < 
1e-5) and I(miRNA;Host|R) > I(miRNA;Host). The mutual information and CMI are 
estimated using adaptive partitioning algorithm. To evaluate the significance of each 
predicted miRNA regulators, the p-value of triplets from the same miRNA regulators are 
integrated using Fisher’s method, where the −2 ln(pk )
k=1
N
∑  follows the chi-square 
distribution and the degree of freedom equals to the number of integrated p-values. 
Cell and Culture Condition 
The glioma-derived cell lines SNB19 were grown in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 10% FBS (GIBCO/BRL). Freshly trypsinized cells 
were suspended at 3x105 cells/ml in standard culture medium and seeded at a density of 
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3x105 cells per well in standard six-well tissue culture plates. After seeding, the cells 
were incubated at 37°C in a 95% air/5% CO2 humidified atmosphere, and one milliliter 
of fresh medium was supplied every other day to the cultures after removal of the 
supernatant. 
Transformation with Heat Shock 
Take competent E. coli, DH5α, cells from –80°C freezer. Turn on water bath to 
42°C. Put competent cells in a 1.5 ml eppendorf. (For transforming a DNA construct, use 
50 µl of competent cells. For transforming a ligation, use 100 µl of competent cells.) 
Keep tubes on ice; then, add 50 ng of circular DNA into E. coli cells. Incubate the 
mixture on ice for 10 minutes. Next is to thaw competent cells: put the tube with DNA 
and E. coli into water bath at 42°C for 45 seconds. Then, put the tube back on ice for 2 
minutes to reduce damage to E. coli. Add 1 ml of LB media without antibiotics and 
incubate the tube at 37°C for 1 hour. Finally, spread about 100 µl of the resulting culture 
on LB plates with appropriate antibiotic added (usually Carbenicillin or Kanamycin). 
Grow overnight at 37°C and then pick colonies after 12-16 hours for further experiments. 
RNA Extraction and Quantitative Reverse Transcription Polymerize Chain 
Reaction 
To perform cell2cDNA and reverse transcription, firstly, remove the medium 
from plate, and wash the plate with cold PBS. Aspirate the PBS and then add trypsin. 
After cells start to detach from plate, inactivate the trypsin with serum, and spin at 4°C 
and remove the supernatant to collect cells. Resuspend the pelleted cells in ice cold PBS, 
spin again at 4°C < 1200g for 5 minutes. 
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Add 100 µl of ice-cold cDNA lysis buffer. Mix the cell and lysis buffer by vortex 
and pipetting, and then transfer the mixture into PCR machine immediately and incubate 
at 75°C for 10 minutes. Cool the sample on ice, and add 2 µl DNAase per 100 µl lysis 
buffer. Mix the sample thoroughly and vortex gently. Put the sample back to PCR 
machine, and incubate the sample at 37°C for 15 minutes, then 75°C for 5 minutes to 
inactivate the DNAase. The RNA sample can be stored at -20°C for one week or at -80°C 
for 2 months. 
To reverse transcription (RT), first of all, mix 5 µl of RNA sample with 2 µl of 
random primers, 8 µl of nuclease free water and vortex the mixture for 10 seconds. 
Incubate the mixture at 65°C for 5 minutes and immediately transfer the sample on ice. 
Add 4 µl of qScript Flex Reaction Mix (5X) and 1 µl of qScript Reverse transcriptase to 
the sample. Mix the sample by vortex for 10 seconds and incubate the sample 10 minutes 
at 25°C, followed by 45 minutes at 42°C and 5 minutes at 85°C. Finally, hold the 
temperature at 4°C. After completing reaction, cDNA sample can be stored at -20°C. 
To perform quantitative RT-PCR for gene, prepare the PCR mixture and samples 
and aliquot into a 96-well plate for ease with multichannel pipet. Every reaction contains 
12.5 µl ABI 2X sybergold buffer with 2 µl primer (3.75mM), 8.5 µl of water and 2 µl of 
sample cDNA. Seal the plate and corners well with plastic film. Spin the plate at 1500 
rpm for 5 minutes. The qRT-PCR was performed using ABI 7300. The thermal cycles of 
reaction include two steps: step 1 (1 cycle) starts with 2 minutes at 50°C followed by 10 
minutes at 95°C. Step 2 starts with 15 seconds at 95°C, followed by 60 seconds at 60°C, 
repeating for 40 cycles. The Ct value of the gene was firstly normalized with internal 
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control, such as GAPDH or RNU44. The value is called delta Ct (dCt). Subsequently, 
normalize the dCt of the gene with the dCt of the same gene from control experiment to 
obtain delta delta Ct (ddCt), which represents the fold change of gene expression. 
Procedure of qRT-PCR for pri-miRNA is the same as qRT-PCR for gene. Every 
reaction of qRT-PCR for pri-miRNA contains 10 µl TaqMan 2X Gene Expression Master 
Mix with 1 µl 20X TaqMan Pri-miRNA Assays, 5 µl of water and 4 µl of sample cDNA. 
SMAD6 primers: forward 5’-ACGGTGACCTGCTGTCTCTT-3’, reverse 5’-
ACGTGACGGTTTTGAGTTCC-3’. DICER1 primers: forward 5’- 
AGGATGAGGAGGAGGAGAGC-3’, reverse 5’-TTTGGGCATTTTCCATTCAT-3’. 
DROSHA primers: forward 5’-CATGCGGAAGAAAGGGATTA-3’, reverse 5’- 
AATGGCAGTCCGATAGGTTG-3’. SLIT3 primers: forward 5’-
CCTGCCCCTACAGCTACAAG-3’, reverse 5’-TTGTTTTCGCAGTCGTTGTC-3’. 





Reverse transfection of siRNA was performed as described previously. Silencer 
Select siRNA of DDX10, DDX11, DDX17, DDX42, RBM39, SMAD6, IGF2BP3 was 
purchased from Life Technologies. DDX10 and triple-flagged tagged SMAD6 vector 
were purchased from GeneCopoeia. The triplet-flag tagged empty vector was provided 
from Dr. Ricardo Dalla-Favera lab. The anti-flag antibody with beads was purchased 
from Sigma-Aldrich. 
" 49 
To perform reverse transfection in 6-well plate, firstly, mix 2 µl siRNA (10 mM) 
and 38 µl optiMEM and incubate for 5 minutes. On the other hand, mix 2 µl RNAiMAX 
and 38 µl optiMEM and incubate for 5 minutes. Add two mixtures together and incubate 
20 minutes. After incub
"
 
Figure 4.4 Vector Map 3 constructs (DDX10, 3xFlag-SMAD6, 3xFlag) 
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ation, add 80 µl mixture with 420 µl media (without antibiotics) and 500 µl diluted cells 
(~105 cells) to each well. 
To perform forward transfection, seed cells on the previous day. Mix 500 µl 
optiMEM and 15 µg of plasmid. On the other hand, mix 500 µl optiMEM and 10 µl 
lipofectamine 200 and incubate at room temperature for 5 minutes. Add two mixtures 
together and incubate for 30 minutes. Remove the media from the plate, and add 5 ml 
media without antibiotics and mixture for lipofection to each well. Due to the toxicity of 
lipofectamine, replace or add media after 6 or 8 hours after performing transfection. 
RNA-immunoprecipitation 
Prepare around 107 or two 15-centimeter plates with full confluency of cells after 
24 hours of transfection. Wash the cells with PBS; then harvest the cells by trypsinization. 
Spin down cell by centrifugation at 1200 rpm for 5 minutes. Resuspend cell in 2 ml PBS, 
2 ml freshly prepared nuclear isolation buffer and 6 ml water, and keep the cells on ice 
for 20 minutes with frequent mixing. Pellet nuclei by centrifugation at 2500g for 15 
minutes. Then, discard the supernatant and resuspend the nuclear pellet with 1ml freshly 
prepared buffer C. Shear the nuclear membrane and chromatin by sonication at high level 
for 15 min. Then, pellet the nuclear membrane and debris by centrifugation at 13000 rpm 
for 10 minutes. Take 20 µl supernatant for loading control. Add beads conjugated with 
antibody to protein of interest (40 µl) to supernatant and incubate at 4°C overnight with 
gentle rotation. Pellet beads at 2500 rpm for 30 seconds, then remove supernatant, and 
resuspend beads with 1000 µl RIP buffer. Repeat washing three to five times with RIP 
buffer to reduce non-specific binding, followed by one time wash with PBS. Then, take 
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20 µl of beads for western blotting. Finally, extract RNA from beads using cell2cDNA in 
order to avoid loss of RNA yield. TaqMan primers of primary miRNAs for qRT-PCR 
were obtained from Life Technologies. 
Statistical Analysis 
All experiments were performed in triplicate. All data were shown in mean ± 
standard error. All statistical analyses were performed by MATLAB or R. The Kaplan-
Meier plot was generated from NCI Repository for Molecular Brain Neoplasia Data 
(REMBRANT) using all glioma samples. 
Cell Proliferation Assay 
Cell proliferation assay for SMAD6: cells were seed in 12-well plate in triplicate 
(200 cells per well). Prepare 7 plates in total for one week. After 24 hours, remove the 
media and fix cells with 4% paraformaldehyde in PBS for 15 min and wash 1x with water. 
Stain with 0.1% crystal violet for 20 min (1 ml per 12-well). Aspirate and wash 3x with 
water and then aspirate and allow to air dry. Add 1 ml 10% acetic acid to each well and 
incubate 20 min with shaking in order to extract proteins. Swirl and pipet up and down 
the lysate. Finally, measure the absorbance of protein lysate at 590nm. 
Cell proliferation assay for IGF2BP2 and IGF2BP3: cells were seeded in 16 well 
plates (E-plate 16, Roche) (4,000 cells in 150 µl medium/well), following the 
xCELLigence Real Time Cell Analyzer (RTCA) DP manual provided by the 
manufacturer (Roche). Cell index, which is proportional to the number of cells attached 
to the culturing surface, is recorded real time every 1-2 hours for up to 3-4 days. For each 
well, the cell index recorded 4 hours after seeding was used as the baseline to get fold 
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changes of cell indices afterwards. The time point of 4 hours after seeding is therefore 
used as time point zero in Figure 4.13 and Figure 4.16. Average fold changes of cell 
index were calculated based on at least two measurements from 4 replicate experiments ± 
SE.  
Preparation of lentivirus 
Plate around 6x106 HEK293T cells in 15 cm dish day before transfection 
(alternatively, split one confluent 15 cm dish into three 15 cm dishes). Ninety to ninety-
five percent of cell confluence is expected when performing transfection. After 24 hours, 
aspirate supernatant and replace with 15 ml of fresh medium (DMEM, 10% FBS, no 
antibiotics). Prepare the mixture of transfection reagent, including 840 ng of pVSV-G, 
7500 ng of pdelta8.9, 8400 ng of pLKO-shSTK38, 1500 µl of jetPrime buffer and 60 µl 
of jetPrime reagent. Vortex the mixture for 10 sec, spin down and incubate at room 
temperature for 10 minutes. Then, add the transfection mixture to the cells, and add 20 ml 
of fresh medium in the evening, so that the total volume of medium for 15 cm plate will 
be 35 ml. On day 3, replace medium with fresh 35 ml of medium. On day 4, collect the 
supernatants with lentivirus into 50 ml conical tubes and add 35 ml of fresh medium to 
plate. Filter supernatant with Steriflip filtration tubes and place the tubes on ice and store 
in the cold room until next day. On day 5, collect 35 ml supernatant for the 2nd time. 
Filter and pool the supernatants together. Combine 3 volume of supernatant with 1 
volume of Lenti-X (around 10 to 12 ml) and then incubate mixture at 4°C overnight. On 
the last day, centrifuge the sample at 1,500xg for 45 min at 4°C. Remove supernatant 
carefully and resuspend off-white pellet in 200 µl of PBS. Finally, titrate the virus with 
Lenti-X stick, split 50 µl of virus in each tube and store in -80°C for future experiments. 
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Infection of lentivirus 
Seed 105 cells in 6-well plate. Next day, mix 5µg/ml polybrene, 100 µl virus and 
add medium to make total volume 600 µl. Then, add the mixture into the well directly. 
On day 3, replace medium with fresh 2 ml of medium. On day 4, replace medium with 2 
µg/ml puromycin for selecting successfully transfected cells (note that the concentration 
of puromycin depends on cell line). After 24 or 48 hours, check cell survival rate. The 
survived cells can be collected for measuring the efficiency of knocking down using 
qRT-PCR. 
4.3 Results 
Identification of post-transcriptional miRNA regulators 
Two thirds of miRBase miRNAs (Rybak, Fuchs et al. 2008) are located within 
transcriptional units that include other miRNAs, non-coding RNAs or mRNAs. To 
identify the post-transcriptional miRNA regulators, we restricted the study of miRNAs 
and their hosts to instances where deviations are associated with lower mature miRNA 
abundance, we exclude deviations due to independent miRNA transcription (Ozsolak, 
Poling et al. 2008). Histone modification of H3K4me3 and H3K27ac are known histone 
markers for transcription start sites and active regulatory elements. Therefore, we also 
used chromHMM data from ENCODE to examine the transcription start sites of the 
intragenic miRNAs (Ernst, Kheradpour et al. 2011). We found 234 out of 290 intragenic 
miRNAs do not have the sign of independent promoters. 
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We screened for post-transcriptional regulators of intergenic miRNAs that are co-
transcribed with other miRNAs, and intragenic miRNAs that are co-transcribed with their 
host genes (Rodriguez, Griffiths-Jones et al. 2004; Gennarino, Sardiello et al. 2009). 
Considering the co-transcribed RNAs that are significantly correlated in glioblastoma 
tumors (Lambertz, Nittner et al. 2010), samples with relatively improved or lost 
correlation harbor the footprints of tumor-specific post-transcriptional regulation. More 
precisely, deviations in correlations between expression profiles of intragenic miRNAs 
and their hosts that results in lower mature miRNA abundance, and deviations in 
correlation between expression profiles of co-transcribed miRNAs must be due to post-
transcriptional events. Our main premise is that RBPs whose expression is significantly 
predicative of such deviations may contribute to the regulation of miRNAs. Consequently, 
we expect perturbations that target these RBPs to affect the abundance of one miRNA 
species but not its co-transcribed counterpart, and perturbation to regulators that enhance 
or inhibit mature miRNA biogenesis are expected to result in matching depletion or 




Table 4.1 Predicted miRNA biogenesis regulator from TCGA GBM data set 
The pairs are the host-miRNA or miRNA cluster pairs regulated by the candidate in the 
prediction (conditional mutual information, p-value < 1e-5). The highlighted genes are 
validated miRNA biogenesis regulators 
"
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Information theory has been successfully applied to infer transcriptional and 
posttranslational network previously. Here, we use conditional mutual information 
identify the relationship of host-miRNA-regulator (p-value < 1e-5), meaning a miRNA 
regulator should be able to significantly improve the relationship between intragenic 
miRNA and its host mRNA. Then, we use Fisher’s method to determine the significance 
of each predicted miRNA RBP regulator. In total, our screen identified 33 candidate RBP 
regulators that target miRNAs, including regulators that are expressed in tumor specific 
manner (Table 4.1). Among candidate RBP regulators, seven are known miRNA 
biogenesis regulators. DDX17, HNRNPA1 increase miRNA level through binding to 
primary miRNAs and facilitate DROSHA processing. On the other hand, LIN28A and 
ILF3 repress the biogenesis of targeted miRNAs by competing against DROSHA binding 
to miRNA precursors. In our prediction, LIN28A is able to modulate the correlation 
between miR-18, miR-92 and their host transcript, MIR17HG. The correlation between 
MIR17HG and miR-18 or miR-92 both increase under lowly-expressed LIN28A 
(spearman correlation, p-value < 1e-4), suggesting LIN28A plays a minor inhibitory role 
in the miRNAs other than the widely-known let-7 family. 
ERN1 is able to terminate miRNA biogenesis through cleaving miRNAs during 
ER stress (Stefani and Slack 2008). Several miRNAs, such as miR-17, miR-34a, miR-96 
and miR-125b, are rapidly decayed by ERN1 in response to ER stress. We predicted 
ERN1 regulates the level of miR-592. MiR-592 and its host, GRM8 is significantly 
correlated when ERN1 is lowly expressed (spearman correlation, p-value < 1e-4), 
suggesting miR-592 is another new target of ERN1 cleavage (Figure 4.5). 
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ILF3 is known to bind small double stranded RNA, such as adenovirus viral-
associated RNAs and miRNA precursors. Heterodimer ILF2-ILF3 associates with over-
expressed DROSHA and interferes miRNA biogenesis by competing against DGCR8 for 
binding to the basal region of certain pri-miRNAs (Sakamoto, Aoki et al. 2009). Previous 
study showed overexpressing ILF3 causes the accumulation of precursors of miR-30a, 
let-7a, miR-15a, miR-16 and miR-21, and the heterodimer ILF2-ILF3 associates with 
these precursors. Here, we predicted ILF3 participates in maturation of miR-550a-5p and 
miR-553. DHX9 contains a DEAH domain, which function as RNA helicase and alters 
RNA secondary structure. It interacts with BRCA1-DROSHA duplex and several pri-
miRNAs. Silencing DHX9 in HeLa cell decreases the level of mature let-7a, miR-16, 
miR-145 and miR-34a. These pri-miRNAs have physical interactions with DHX9 as well. 
Here, we identified DHX9 as biogenesis regulator by affecting the relationship between 
miR-330 and its host gene, EML2. 
Biochemical target identification 
 
""""""""""""""""""""""""""""" "
Figure 4.5 The relationship between miR-592 and its host, GRM8 is associated with 
ERN1 expression.  
ERN1 is a validated miRNA post-transcriptional regulator. 
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To test the validity of our method to identify miRNA biogenesis regulators, we 
use qRT-PCR to measure the pri-miRNA and mature miRNA. First, we observe silencing 
DDX17, a validated miRNA posttranscriptional regulator, causes the downregulation of 
several mature miRNAs in SNB19 cell. While depleting another RNA-binding protein, 
RBM39, which is not identified in our prediction, has no effect on the tested mature 
miRNAs or precursors (Figure 4.6).  
Since three genes containing DEAD or DEAH domain (DDX5, DDX17 and 
DHX9) have been shown to modulate miRNA at posttranscriptional stage, we firstly 
"""""""""""""""""" "
Figure 4.6 DDX17 and RBM39 as positive and negative control in qRT-PCR validation.  
DDX17 is a validated miRNA biogenesis regulator, and silencing DDX17 affects the level of 




selected three candidates in DDX family throughout the prediction for further validation. 
DDX10 regulates the maturation of miR-218, which is co-transcribed with SLIT3 in our 
prediction. Overexpression of DDX10 only increases mature miR-218 level by 30% but 
not affecting the host gene, SLIT3. Depletion of DDX10 and DDX42 both downregulate 
the level of mature miRNAs, including miR-423-3p, miR-423-5p, miR-24, miR-590, 
miR-324 and miR-25 (Figure 4.8). Meanwhile, the levels of miRNA precursors remain 
unaffected or upregulated indicating both DDX10 and DDX42 modulate mature miRNA 
level at posttranscriptional stage. On the other hand, silencing DDX11 has similar effect 
as DDX10 on miR-423-3p: both downregulate mature miR-423-3p and causes 
accumulation of pri-miR-423.  
"
Figure 4.7 DDX10 regulate the maturation of miR-218.  
(A) RNA-binding protein, DDX10 affects the relationship between host mRNA, SLIT3 and 
intragenic miRNA, miR-218. The host mRNA and intragenic miRNA are only correlated when 
DDX10 is highly expressed. (B) RT-PCR showed overexpression of DDX10 upregulates miR-







However, DDX11 seems to interfere the processing of miR-10b, miR-196a-2 and 
miR-24. All these mature miRNAs are significantly increased upon silencing DDX11. 
We selected these candidates throughout the prediction and validated with qRT-PCR. The 
results showed, in addition to DDX5, DDX17 and DHX9, more proteins in DDX family 




Figure 4.8 More DDX family members participate in miRNA maturation.  
Various mature miRNA and miRNA precursors differentially expressed under siRNA mediated 
silencing DDX10, DDX11 and DDX42""
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SMAD6 regulate miRNA biogenesis 
SMAD proteins contain three classes: the receptor-regulated SMADs (R-SMAD), 
the common-mediator SMADs (co-SMAD), and the antagonistic SMADs (I-SMAD). 
The R-SMADs, including SMAD1, SMAD3 and SMAD5, promote the maturation of a 
subset of miRNA by binding to SMAD-binding elements on miRNAs and facilitating 
DROSHA cleavage. SMAD6 is a member of I-SMAD, a class that counteracts against R-
SMAD in transcriptional regulation. However, SMAD6 possess the same protein 
domains as R-SMAD proteins, and we predicted SMAD6 a candidate miRNA biogenesis 
regulator like other R-SMAD. To validate if SMAD6 regulates miRNA maturation, we 
silenced SMAD6 with SMAD6-specific siRNA and performed miRNA profiling using 
Wafergen. We found 9 out of 16 predicted miRNAs are significantly affected when 
silencing SMAD6 (Fisher’s exact test, p-value < 0.01), suggesting SMAD6 has similar 
function with other R-SMADs in miRNA biogenesis (Figure 4.9A). From the 
downregulated miRNA precursor sequences, we identified a motif similar with the 
consensus sequences of SMAD binding element. (Figure 4.9 B) 
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To examine whether SMAD6 affects miRNA biogenesis post-transcriptionally, 
we selected miRNAs that are highly expressed in SNB19 then measured the level of pri-
miRNA and mature miRNA with qRT-PCR simultaneously. When silencing SMAD6, 10 
selected mature miRNAs are significantly downregulated, while the levels of their 
primary transcripts are all increased. It indicates SMAD6 affects the miRNA maturation 
  
                                                     
 
Figure 4.9 SMAD6 regulate miRNA post-transcriptionally.  
(A) Ten mature miRNAs are downregulated while their eleven precursors are accumulated when 
knocking down SMAD6. Noted that miR-24 can be expressed from two different loci  (B) 
SMAD6 has two modes of regulations of miRNAs. The levels of mature miRNAs were measured 
by Wafergen. MiRNAs with Asterisk represent the candidate miRNAs regulated by SMAD6 in 
the prediction (p-value <1e-2) (C) The sequence motif identified from SMAD6 affected miRNA 







at post-transcription stage (Figure 4.9 A). Furthermore, we biochemically tested if 
SMAD6 physically associates with miRNA precursors using RNA-immunoprecipitation 
(RNA-IP). RNA-IP indicated that SMAD6 interacts with the primary transcripts of tested 
miRNAs (mir-196-2, mir-324, mir-590, mir-18a and mir-130b), but not with mir-10b 
where the mature miRNAs and primary transcripts are not differentially expressed by 
knocking down SMAD6 (Figure 4.10). 
 




Figure 4.10 SMAD6 interacts with pri-miRNA.  
(A) RIP showed SMAD6 interacts with five pri-miRNAs, mir-196-2, mir-324, mir-590, mir-
18a and mir-130b, which are significantly accumulated when knocking down SMAD6. The 
fold changes are the enrichment status of pri-miRNA after 24hr ectopic expression of 3X-
flag-tagged SMAD6 compared to 3X-flag-tagged empty vector. (B) Western blotting showed 
SMAD6 is enriched after pulling down with anti-flag antibody. 
B"A"
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IGF2BP1 is another predicted miRNA biogenesis regulator. IGF2BPs family 
includes IGF2BP1, IGF2BP2 and IGF2BP3, and they all carry two RNA recognition 
motifs, six hnRNP K homology domains and have identical binding profiles. Due to 
IGF2BP1 is poorly expressed in SNB19 cell; we validated the role of the highly 
expressed IGF2BP2 and IGF2BP3 in miRNA regulation. We profiled miRNA 
expressions with Wafergen, after siRNA-mediated silencing of IGF2BP2 and IGF2BP3. 
"
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Figure 4.11 IGF2BP3 regulates miRNA level post-transcriptionally.  
(A) Fifteen mature miRNAs are significantly repressed when knocking down IGF2BP3 while 
eight of their precursors are accumulated. Noted that the precursors of miR-423-5p and miR-
423-3p, miR-18a and miR-17 were measured by same primers. (B) The levels of mature 
miRNAs were measured by Wafergen, and the candidate IGF2BP3-regulated miRNAs tend to 
be downregulated when silencing IGF2BP3. MiRNAs with Asterisk represent the candidate 
miRNAs regulated by IGF2BP3 in the prediction (Fisher’s exact test, p-value <0.004) (C) The 
sequence motif found from IGF2BP3 affected miRNA precursors compared to IGF2BP3 
binding motif from PAR-CLIP 
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Fifteen out of thirty predicted miRNAs are significantly affected upon silencing IGF2BPs 
(Fisher’s exact test, p-value < 0.004). Similar with SMAD6, qRT-PCR also showed the 
fifteen highly expressed miRNAs are downregulated by silencing IGF2BP3, and their 
primary transcripts are all accumulated (Figure 4.11 A). This indicates IGF2BP3 is a 
posttranscriptional regulator of miRNA biogenesis, and knocking down IGF2BP3 
interferes the processing from pri-miRNA to mature miRNA. Notably, miR-17 is a 
predicted IGF2BP target, but it is not differentially expressed in the Wafergen system 
(Figure 4.11 B). We validated miR-17 with RT-PCR again and found out the mature and 
primary transcripts of miR-17 were both affected upon IGF2BP3 perturbation. The 
previous work of PAR-CLIP showed IGF2BP2 and IGF2BP3 recognize a (CAUH) motif 
on bound mRNA. We identified a similar motif from the validated miRNA sequences 
(Figure 4.11 C). 
4.4 Discussion 
The maturation of miRNA is finely controlled transcriptionally and post-
transcriptionally, and the miRNA level is important to miRNA-mediated regulation. 
Study has shown lowly expressed miRNA may not have the ability to regulate target 
mRNA expression (Mullokandov, Baccarini et al. 2012). Moreover, a large number of 
miRNAs have significantly lower expression levels in tumors and cancer cell lines than 
in normal tissues, indicating the miRNA-mediated regulation is dysregulated in various 
types of tumors (Lu, Getz et al. 2005). Currently, a dozen of posttranscriptional 
regulators have been identified modulating miRNA level in various contexts by 
interacting with miRNA precursors, DROSHA and DICER1. Here, we performed a 
computational screening to identify candidate miRNA biogenesis regulators from RNA 
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binding proteins. We predicted 33 RBPs may be involved in miRNA regulation, and 
seven of them are validated miRNA regulators. We carried out qRT-PCR to measure the 
pri-miRNA and mature miRNA level upon perturbing the predicted miRNA regulators. 
Silencing DDX10, DDX11, DDX42, SMAD6 and IGF2BP3 cause a subset of miRNAs 
and their precursors significantly differentially expressed. Furthermore, we showed the 
physical interactions between SMAD6, IGF2BP3 and miRNAs. 
SMAD6 is an inhibitory SMAD, and its major function is to by interfering the 
interaction between SMAD4 and R-SMADs. Current understanding of SMAD6 binding 
to nucleic acid is not clear. However, like other SMAD family member, SMAD6 contains 
a Mad Homology 1 (MH1) domain for nucleic acid binding. Previous study has shown 
SMAD6 is able to regulate Id2 and Hex by binding to their promoter regions and is 
required cell differentiation in HL-60 cell (Lu, Getz et al. 2005; Glesne and Huberman 
2006). In this study, we further identify SMAD6 possess the ability to bind miRNAs and 
modulate miRNA maturation. 
To study SMAD6 function in glioblastoma, we silenced SMAD6 in SNB19 using 
lentivirus carrying SMAD6-specific shRNA. After puromycin selection for 48 hours, 
only cells infected by lentivirus survived, and the survived cells are stable cell lines. 
SMAD6 level in this stable cell line was knocked down by around 90% and their cell 
morphology turned into irregular while the morphology of stable cell line with non-
targeting control is still similar with original SNB19. This suggests SMAD6 could block 
epithelial-mesenchymal transition (EMT) in glioblastoma context (Figure 4.12 B). 
Previous studies have shown SMAD6 inhibits EMT during cardiac valve formation and 
in the proepicardium (Desgrosellier, Mundell et al. 2005; Olivey, Mundell et al. 2006). 
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However, the cell proliferation assay showed there is no significant difference between 
shSMAD6 and shNT cell lines in proliferation (Figure 4.13). Interestingly, knocking 
down SMAD6 in SNB19 cell using SMAD6-specific shRNA or siRNA both induced 
significant reduction of DICER1 mRNA level while DROSHA is not affected. This 
suggests the transcription of DICER1 may be regulated by conventional SMAD pathway 







Figure 4.12 Silencing SMAD6 using shRNA in SNB19 cell.  
(A) SMAD6 mRNA level were repressed by 90% in the two shSMAD6 stable cell 
lines (B) Two shSMAD6 cell lines have significant morphological change while shNT 
cell line is still like original SNB19 cell (C) Silencing SMAD6 with shRNA also 
brings down DICER1 expression. The association between SMAD6 and DICER1 was 







IGF2BP family (IGF2BP1, IGF2BP2 and IGF2BP3) carry six RNA binding 
domain: four KH domains and two RRM domains, and their protein domain structures 
and binding motif are highly similar. Based on PAR-CLIP data, they tend to bind exonic 
"""""""""""""""""""""""""""" "
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Figure 4.14 IGF2BP3 interacts with miR-196-2. 
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region and have slight preference to 3’ UTR. The binding of IGF2BP protein can prevent 
mRNA from degradation. From PAR-CLIP of IGF2BP family from HEK293 cell, we 
found these proteins not only interact with mRNA but with miRNA as well. Each 
IGF2BP protein interacts with roughly 400 miRNAs in HEK293 cell with more than 10 
RPM. This observation indicates IGF2BP family has the ability to interact with miRNA 
and slow the miRNA turnover rate. Figure 4.10 showed IGF2BP3 binds to miR-196a-2, 
which is predicted to be target of IGF2BP1 in our prediction. 
IGF2BP3 is upregulated in various types of tumor and modulate miRNA level in 
our prediction. To examine the biological significance of IGF2BP3 regulating miRNA 
level, we screened for the common targets of IGF2BP3 modulated miRNAs, and one 
common candidate is the tumor suppressor gene, PTEN. The miRNA profile from qRT-
PCR showed IGF2BP3 regulates the maturation of multiple miRNAs (miR-26a, miR-19a, 
miR-19b, miR-106a, let-7b, let-7c) known to target PTEN. MiR-26a was also bound by 
IGF2BP family (Figure 4.15). We measured PTEN 3’ UTR luciferase activity in SNB19 
"""""""""""""""""""""""""""""""""""""""""""""""" "
Figure 4.15 IGF2BPs binds to the oncomiR, miR-26a. 
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cells transfected with mock and IGF2BP3-specific siRNA. The result showed PTEN 3’ 
UTR luciferase activity is increased by nearly 40% with IGF2BP3 knockdown, indicating 
IGF2BP3 regulates PTEN through PTEN 3’UTR. To test the regulation of IGF2BP3 on 
PTEN is miRNA mediated, we co-silenced DICER1 and IGF2BP3 and measured PTEN 
mRNA level (Figure 4.16 B). The expression of PTEN is significantly lower when 
IGF2BP3 and DICER1 were knocked down simultaneously than IGF2BP3 alone, 
suggesting that silencing DICER1 abrogated the regulation of IGF2BP3 on PTEN. 
Therefore, the regulation of IGF2BP3 on PTEN is miRNA mediated. PTEN is known to 
induce apoptosis and cell cycle arrest; therefore, we asked whether silencing IGF2BP3 
have significant physiological effect through PTEN. IGF2BP3 is amplified in 40% of 
samples in TCGA GBM data set (aCGH ratio above 0.3). The REMBRADT database 
showed glioma patients with high IGF2BP3 expression (>= 2.0X) have significantly 
shorter survival rate than patients with normal IGF2BP3 expression (p-value < 1e-4 by 
log-rank test, Figure 4.16 A). The same clinical outcome also happens on the glioma 
patients with high IGF2BP2 level (>= 2.0X). We measured the cell proliferation rate of 
SNB19 cells transfected with IGF2BP3-specific shRNA. Knocking down IGF2BP3 
decreases PTEN targeting miRNAs, so the increased PTEN is able to slow down the cell 




































Figure 4.16 IGF2BP3 associates with patient prognosis and cell growth.  
(A) Kaplan-Meier plot showed the prognosis status of glioma patients in 
REMBRANT given SMAD6, IGF2BP2 and IGF2BP3 expression. Patients with high 
IGF2BP3 expression (upregulated more than 2 folds) have worse survival curve 
compared to patients with intermediate IGF2BP3 expression (upregulated and 
downregulated less than 2 folds). Statistical significance was determined by log-rank 
test. (B) IGF2BP3 regulates PTEN level via miRNA regulation (C) Cell proliferation 
assay of SNB19 cells was performed at 5 minutes interval and up to 70 hours, 
following shRNA mediated IGF2BP3, DICER1 and DROSHA silencing. Silencing 
B2M was used as negative control. 
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Chapter V 
Identification for miRNA activity modulators 
5.1 Introduction 
MiRNA-mediated post-transcriptional regulation has emerged as a key gene 
regulation mechanism in diverse biological pathways. These small RNAs recognize 
target mRNAs and repress their expression through two distinct pathway, mRNA 
degradation or translational repression. It is estimated around 30% to 60% genes are 
under regulation of miRNA, and each miRNA can target up to 200 different mRNAs. 
The initial observation of miRNA-mediated regulation was observed in C. 
elegans. Lee et al. found lin-4 small RNA is partial complementary to the 3’ UTR of its 
target mRNA, lin-14 (Wightman, Ha et al. 1993). Subsequently, lin-4 and let-7 also 
found complementarity in 3’ UTR of lin-28 and lin-41, respectively (Seggerson, Tang et 
al. 2002). When hundreds of miRNAs identified using computational prediction or 
biochemical cloning from various model organisms, people realize this type of small 
RNA brings huge impact to our understanding of gene regulation. In miRNA field, the 
most important problem is how miRNAs recognize their target mRNAs. The first 
observation is that the pairing between miRNAs and their target mRNA followed 
Watson-Crick sequence complementarity. Plant miRNAs usually form nearly perfect 
RNA duplex with their target mRNAs and induce subsequent post-transcriptional 
regulation. This phenomenon indicates it is simpler to identify miRNA targets in plants 
merely based on sequence complementarity. In animal, partial sequence complementarity 
between miRNA and mRNA is sufficient to induce miRNA-mediated regulation. Animal 
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miRNAs’ 2nd-7th nucleotides are called “seed” region. Perfect pairing between seed 
region and target 3’ UTR is essential for miRNA-mediated regulation. Multiple 
validations in different organisms all showed that substituting nucleotides in the seed 
region dramatically reduce the ability of miRNA targeting its target. This observation 
became the major principle of miRNA target prediction algorithms. Notably, more and 
more non-canonical miRNA-target interactions, where no perfect match between seed 
region and 3’ UTR, were identified using crosslinking and high-throughput sequencing 
technology. The miRNA seed region is usually the most evolutionary conserved region in 
a mature miRNA, meaning miRNA seed region tend to be preserved under selection 
pressure. On the other hand, miRNA target sites are more conserved as well compared to 
flanking 3’UTR region. This feature was adopted as additional principle by many target 
prediction algorithm as well (Lu, Getz et al. 2005; Bartel 2009). 
In addition to the 5’ seed region of miRNA, 3’ end of miRNA participates in 
pairing target mRNA in certain situations. Although seed region pairing is sufficient to 
initiate miRNA regulation, thirteenth-to-sixteenth nucleotides of mature miRNA pairing, 
3’-supplementary sites, may serve as a supplement to seed pairing (Shin, Nam et al. 
2010). In this case, the 3’-supplementary sites on miRNA target also tend to be more 
evolutionally conserved than flanking region. Pairing between 3’ end of miRNA and 
target mRNA sometimes provide more than supplementary role. It can compensate the 
minor imperfect pairing, such as one nucleotide bulge or internal loop, between seed 
region and miRNA target site although this situation is atypical (Shin, Nam et al. 2010). 
Computational predicting miRNA target always results in dozens of highly 
significant candidate targets. To obtain true candidates from the prediction, we can 
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validate the target using genetic or biochemical methods. In principle, genetic methods 
validate the miRNA-target interaction in vivo by performing gain or loss of function 
experiments and observing the phenotypes. The advantage of genetic method is the 
identified targets will be important physiologically in the tested model organism and 
disrupting the regulation of miRNA to the target causes the observable mutant phenotype. 
The caveat is the identified genetic interaction could be argued that it is an indirect 
interaction between miRNA and target; meaning the tested miRNA recognizes other 
target mRNA that mediates the expression of hypothesized target. Also, if the phenotype 
is controlled by multiple genes, which is common in higher organisms, then the 
phenotype may be too subtle to be detected. On the other hand, biochemical methods 
provide direct evidence to illustrate the interaction between miRNA and target mRNA. 
Earlier approaches include knocking down or overexpressing miRNA and measure the 
expression of predicted targets using luciferase assay, qRT-PCR, western blotting or 
ELISA. Furthermore, the 3’UTR sequence can be altered by site-directed mutagenesis in 
order to find out the precise miRNA binding sites. Recently, two methods, HITS-CLIP 
and PAR-CLIP, were developed utilizing crosslinking of protein-RNA interactions and 
immunoprecipitation (CLIP) to detect the precise RNA-binding protein binding sites on 
the bound RNAs (Chi, Zang et al. 2009; Hafner, Landthaler et al. 2010). Both methods 
accompanied with next generation sequencing are called CLIP-seq. This approach with 
Argonaute2 pull-down enables the identification of miRNAs and their endogenous targets 
in a transcriptome-wide scale and potentially the actual miRNA-binding sites on the 
3’UTRs. Surprisingly, many noncanonical miRNA binding sites were identified in this 
study, which do not carry the perfect seed-matching motif. This observation suggests the 
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miRNA-targeting mechanism is much more complicated than what we currently 
understood and/or mRNA bound by miRISC alone does not guarantee that it is regulated 
by miRNA-mediated regulation. 
MiRNAs regulate target mRNA expression through mRNA degradation and 
translational repression. The mRNA degradation can be done via two pathways:  1) 
Perfect pairing between miRNA and mRNA induces endonucleolytic cleavage by 
Argonaute2 in bound miRISC. This is the fastest mechanism to regulate target mRNA 
level. This pathway occurs commonly in plants but rarely in animal due to the imperfect 
pairing between animal miRNAs and their target mRNAs. 2) Partial miRNA-target 
pairing induces deadenylation of target mRNA through recruiting CCR4-NOT by 
miRISC component, GW182. Loss of the poly-A tail induces dissociation of poly-A 
binding protein, PABPC and leads to degradation of target mRNA. Two different 
pathways comprised of translational repression by miRNA: the first pathway is to recruit 
CCR4-NOT complex to block translational initiation while the other pathway is to block 
translation after the process has been initiated. The second pathway of translational 
repression occurs after translational initiation. In this pathway, miRISC complex can 
induce dissociation of ribosome from target mRNAs or proteolysis of nascent 
polypeptides. Interestingly, there are also studies showing miRNA binding can stimulate 
protein expression under certain conditions. Upon cell cycle arrests, TNFα mRNA is 
targeted by miR-369-3, and FXR1 is recruited by Argonaute in miRISC simultaneously 
in order to activate the translation of TNFα. Another study also showed FXR1 
upregulates the translation along with Argonaute in Xenopus laevis oocyte (Mortensen, 
Serra et al. 2011). The other example is miR-10a binds 5’UTR of ribosomal mRNA and 
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upregulates the expression of ribosomal protein, and this finding suggests miR-10a can 
potentially induce protein synthesis globally (Vasudevan, Tong et al. 2007; Orom, 
Nielsen et al. 2008). Despite of three examples above, it is still very rare to find miRNAs 
positively regulate the expression of target mRNAs. 
Four distinct types of miRNA-mediated regulation were introduced above, and 
several attempts have been made to understand which miRNA-mediated pathway is 
predominantly adopted. Selbach et al. and Baek et al. both utilized SILAC to monitor the 
global change in protein level caused by miRNA regulation. When comparing the fold 
change of proteins and mRNAs, they concluded the majority of target mRNAs were 
regulated via mRNA degradation. Another work utilized ribosomal profiling to measure 
the overall effect of miRNA regulation on translation efficiency and compare with the 
simultaneously performed mRNA profiling. They found more than 84% of protein 
downregulation were accounted for lowered mRNA level. All these results indicate 
mRNA degradation was the predominant pathway in miRNA-mediated regulation in 
mammalian system (Guo, Ingolia et al. 2010). Due to the high frequency of imperfect 
pairing between mammalian miRNAs and target mRNAs, we can further claim that 
miRISC regulate mRNA level mainly through CCR4-NOT induced deadenylation. 
Deadenylated mRNAs are then brought to P-body (processing body) by GW182 and 
being degraded. 
In addition to miRISC, the efficiency of miRNA-mediated regulation is also 
determined by various factors. The first factor is the location of miRNA binding site. 
MiRNA not only binds to 3’UTR but also coding region or 5’UTR. However, the binding 
of miRISC to coding region may be disrupted by ribosome. Post-translational 
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modification of Argonaute is another factor in miRNA targeting efficiency. Prolyl-4-
hydroxylation of Argonaute stabilizes the Argonaute protein itself and enhances miRISC 
activity, while phosphorylation, ubiquitylation and poly-ADP-ribosylation on Argonaute 
protein decreases its affinity to small RNA, destabilizes the protein and interferes the 
target accessibility, respectively. RNA-binding protein is another major factor affecting 
miRNA activity, and the locations of binding sites determine the role of RNA-binding 
protein in miRNA pathway. In zebrafish, the binding sites of DND1 on several target 
mRNAs are in the proximity of miR-430 target sites; hence DND1 competes against 
miRISC and serve as negative modulator of miRNA regulation. ELAVL1 possesses dual 
functions in the modulation of miRNA efficiency. ELAVL1 has preference to bind to 
3’UTR of target mRNA. Over 75% of 3’ UTRs with Argonaute-binding also contains 
ELAVL1 binding sites. Notably, only ELAVL1 binding sites overlapped with miRISC 
binding sites have adverse effect to miRNA activity; otherwise, ELAVL1 can act as a 
positive modulator of miRNA pathway. 
In addition to RNA binding proteins, recent study showed RNA editing plays a 
role in modulating miRNA regulation as well. ADAR1 mediates RNA editing by 
converting adenosine to inosine in the double strand RNA region. The RNA editing alters 
the secondary structure of miRNA precursor and affects miRNA biogenesis. Besides 
modifying miRNA precursors, ADAR1 also edits the 3’UTR of the Rho GTPase 
activating protein 26 (ARHGAP26) and disrupts the binding sites of miR-30-3p and miR-
573 causing the upregulation of ARHGAP26 mRNA and protein level. The last factor of 
miRNA activity modulation is Argonaute-interacting protein. Studies have shown 
Argonaute binding ability is modulated by its cofactors, including NHL2, LIN41 and 
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Mei-P26 (Neumuller, Betschinger et al. 2008; Hammell, Lubin et al. 2009; Rybak, Fuchs 
et al. 2009). Some negative modulators affect the stability of Argonaute or its binding 
affinity to small RNA and target mRNA; the detailed mechanism of positive modulators 
is not clear though. Currently, only a dozen genes were identified to affect miRNA 
activity in different contexts and model organisms. One miRNA activity modulator, Mei-
P26, was identified to decrease AGO2 affinity to target mRNAs in D. melanogaster; 
however, there is no homologous gene of Mei-P26 in mammals. This shows our 
understanding about the miRNA-mediated regulation is still poor, and we need to have a 
better method to identify the remaining miRNA activity modulators more efficiently.  
The goal of this study is to identify genes affect miRNA activity, and we focused 
on RNA-binding proteins and miRISC-interacting proteins. Due to miRISC induces 
mRNA degradation to the majority of target mRNAs; we assumed there is observable 
relationship between miRNA and target mRNA from miRNA and mRNA expression 
profiles. We can therefore identify miRNA modulators that are able to disrupt or improve 
the miRNA-target relationship. Figure 5.1 showed the three-way relationship of miRNA-
target-modulator we plan to identify in this study. 
5.2 Material and Methods 
Data source 
The list of validated miRNA-target interactions in human was collected from 
miRecords and miRTarBase (Xiao, Zuo et al. 2009; Hsu, Lin et al. 2011). The collected 
miRNA-target interactions only validated by low-throughput experiments, such RT-PCR, 
western blot, ELISA or luciferase assay. Some validated miRNA-target interactions were 
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further validated by site-directed mutagenesis. On the contrary, high-throughput 
experiments, such as microarray and SILAC (stable isotope labeling with amino acids in 
cell culture), identify affected mRNA or protein upon disrupting endogenous miRNA 
level, but those affected mRNA or protein could be indirectly regulated by miRNA. 
Gene and miRNA expression profile was obtained from TCGA Breast invasive 
carcinoma (BRCA) data portal (Paroo, Ye et al. 2009). RNA-seq from breast cancer 
patients were performed by Illumina HiSeq, and miRNA-seq was performed by Illumina 
HiSeq and Genome Analyzer. The libraries undergo QC assessment and then trimmed 
adaptor. The reads are mapped to reference genome using BWA alignment. Only reads 
with perfect match to genome are kept for further analysis. The number of reads for each 
gene and miRNA represented RPKM (reads per kilobase per million reads) and RPM 
(reads per million reads). The RNA-seq and miRNA-seq are paired using sample ID, and 
the processed data set consists of 820 samples. 
Another gene and miRNA expression profiles were obtained from METABRIC 
(The Molecular Taxonomy of Breast Cancer International Consortium) (Melo, Ropero et 
al. 2009; Dvinge, Git et al. 2013). Gene expression was profiled by Illumina HT-12 v3 
array, and miRNA expression on customized Agilent array. The gene and miRNA 
expression profile are paired by sample ID and the processed data comprised of 1302 
samples. 
The list of RNA binding proteins was obtained from Gene ontology. The protein-
protein interactions were downloaded from StringDB and PrePPI (Franceschini, 
Szklarczyk et al. 2013; Zhang, Petrey et al. 2013). Predicted miRNA target interactions 
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were obtained from Targetscan (Lewis, Burge et al. 2005; Grimson, Farh et al. 2007; 
Friedman, Farh et al. 2009; Garcia, Baek et al. 2011) with context score higher than 80, a 
cutoff suggested by system. 
Screening for miRNA activity modulators 
The strategy to identify miRNA activity modulators (M) is similar with miRNA 
biogenesis regulators described in Chapter 4. We calculated the conditional mutual 
information between miRNA and target given any candidate gene, I(miRNA;target|M). 
The statistical significance of CMI is evaluated using null distribution of CMI built from 
shuffling of candidate miRNA modulator’s sample identity while maintaining the 
expression of miRNA and targets constantly. All significant triplets have significant CMI 
with p-value less than 1e-5, and I(miRNA;target|M) > I(miRNA;target). The computation 
of mutual information and conditional mutual information was performed as described 
previously. To determine the significance of all predicted modulators, the p-value of all 
significant triplets were integrated by candidate modulators using Fisher’s method. 
Determining the mode of action 
For each predicted miRNA modulator, the whole data set was sorted according to 
the expression of tested modulator. Then, we selected the samples with highest and 
lowest (for example, top and bottom 30%) expression of tested modulator. The 
relationship between miRNA and target in two tails of the sample set was calculated 
using mutual information or spearman correlation. Then, check all predicted miRNA-
target pairs to see if they have better relationship when the predicted modulator is highly 
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or lowly expressed. Compare the ratio to unpredicted miRNA-target pairs using Fisher’s 
exact test to determine the mode of action of predicted modulators. 
Cell and culture condition 
The breast cancer cell line, HCC1395, was obtained from Columbia Genome 
Center. It was grown in RPMI-1640 medium supplement with 10% fetal bovine serum 
(GIBCO/BRL). HCC1395 cells were incubated at 37°C in a 95% air/5% CO2 humidified 
atmosphere. Fresh RPMI medium was supplied every other day to the cultures after 
removal of the supernatant. 
RNA Extraction and Quantitative Reverse Transcription Polymerize Chain Reaction 
The RNA extraction, quantitative PCR with reverse transcription to measure the 
expression levels were performed as described previously. The primers of AGO2 and 
EGFR were obtained from Sigma-Aldrich. EGFR primers: forward 5’-"
CAGCGCTACCTTGTCATTCA-3’, reverse 5’-" TGCACTCAGAGAGCTCAGGA-3’. 
AGO2 primers: forward 5’-TCGCACTATCACGTCCTCTG-3’, reverse 5’- 
ATGGCTTCCTTCAGCACTGT-3’. EGFR primers: forward 5’- 
CAGCGCTACCTTGTCATTCA-3’, reverse 5’- TGCACTCAGAGAGCTCAGGA-3’. 
WNT7A primers: forward 5’-CCCGGGCGGGCTATGTTGATT-3’, reverse 5’-
GCTTGCGCCCAGAGCTACCA-3’. WIPF2 primers: forward 5’-
CAGCCCGAGACCCTCCCAGT-3’, reverse 5’-GCCCAGCTGGCGTCCTTGA-3’. 
PALB2 primers: forward 5’-TCTGTCGCCTGCCCGATGGA-3’, reverse 5’-
CGCTGAAGGCGGGCTAGTGT-3’. 
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RNA interference and Reverse transfection 
EGFR specific siRNA was obtained from Columbia Genome Center. Reverse 
transfection was performed as described previously in Chapter 4.  
5.3 Results  
Collected miRNA-target interactions were validated with mutual information and 
spearman correlation to ensure the relationship existing in two breast cancer data sets. 
From various databases, I collected 2374 experimentally validated human miRNA-target 
interactions from different contexts. All collected interactions were validated by low-
throughput biochemical methods. Due to the majority of miRNA-target interaction leads 
to mRNA degradation in mammalian system, we hypothesize there is measurable 
relationship between miRNAs and their targets. In total, 672 miRNA-targets interactions 
are found to have significant mutual information and anti-correlation in TCGA breast 
cancer (BRCA) data set. MiR-21 and miR-17 are known as oncomiRs for targeting tumor 
suppressor genes, such as PTEN, PDCD4 and RB1, and it is significantly highly 
expressed in various types of tumor. Among the 672 selected miR-target pairs, miR-21 
and miR-17 comprises of 29 and 28 pairs, respectively, showing that they have been 
widely studied and they both actively regulate the target mRNAs in breast cancer context.  
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We use conditional mutual information to identify the triplets of miRNA-target-
modulator with significant p-value (conditional mutual information, p-value < 1e-5). 
Similar with the idea of finding miRNA biogenesis regulator, a miRNA activity 
modulator improves the relationship (anti-correlation) between the miRNA and its targets. 
To find out which gene is significant, we use Fisher’s method to integrate p-values from 
all significant triplets by activity modulators. In total, 4732 miRNA-target-modulator 
triplets have significant conditional mutual information from TCGA BRCA data set. The 
table showed top 20 candidates miRNA modulators. Interestingly, EGFR is the best 
candidate in this analysis, modulating 44 miRNA-target interactions. We repeated the 
same analysis using another independent breast cancer data set, METABRIC. We 
identified 1364 significant triplets, which consist of 339 candidate miRNA modulators. 
!!!!!!!!!!!! !
Table 5.1 Candidate miRNA activity modulators from TCGA BRCA and 
METABRIC. 
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NDN is the top candidate miRNA modulator in METABRIC analysis while EGFR is the 
second candidate regulating 31 miRNA-target pairs. We compared the results from 
METABRIC and TCGA using GSEA (Gene Set Enrichment Analysis) and found out the 
results from these two data sets are highly similar (GSEA, p-value < 1e-5), suggesting 
this method is robust to identify consistent output from independent sources. It also 
showed the candidate modulators identified in both predictions are highly likely to play a 
role in miRNA-mediated regulation in breast cancer. 
 
Most of validated miRNA activity modulators have obvious mode of action, 
facilitating or interfering, in regulating miRNA targeting given present studies. For 
example, DND1 acts as a negative miRNA modulator by competing against miRNA 
binding to target motif. FMRP or PUF were found to bind 3’UTR and stabilize the 
                                    
          METABRIC candidates in TCGA BRCA           TCGA BRCA candidates in METABRIC 
Figure 5.2 Significant enrichment between the predictions from TCGA BRCA 
and METABRIC.  
The top 100 candidate miRNA activity modulators from METABRIC also have high 
ranking in TCGA, and vice versa. The enrichment analysis was performed by GSEA, 
and both analyses showed significant enrichment with p-value less than 1e-5 
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neighboring miRISC binding to target mRNA. ELAVL1 is the only case that play dual 
role in regulating miRNA activity. To determine the mode of action of candidate miRNA 
modulators, we sorted the samples according to the expression of the testes modulator. 
The samples with highest and lowest expression of modulators were then selected. In 
"""""""""""""""""""
"
Figure 5.3 Flowchart to determine mode of action of miRNA modulator. 
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each sample set, the relationship between miRNA and target was measured using mutual 
information and spearman correlation. By summarizing the response of all regulated 
miRNA-target interactions, we can determine the mode of action of miRNA modulator 
(Figure 5.3).  This analysis showed EGFR is a positive miRNA activity modulator: when 
""""""""""""" "
Table 5.2 EGFR, FYN and TRIM29 are all positive miRNA modulator in TCGA 
BRCA and METABRIC.  
Most of miRNA-target pairs modulated the miRNA modulators have better MI, while 
the miRNA-target pairs  
"
"
Figure 5.4 Mode of action of candidate miRNA activity.  
Thirty and seven candidate miRNA activity modulators from TCGA BRCA and 
METABRIC have significant mode of action, respectively. Three genes, EGFR, FYN 
and TRIM29, are significant in both data sets. P-values were estimated using Fisher’s 
exact test. 
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EGFR is highly expressed, it improves the relationships of 37 out of 44 modulated 
miRNA-target pairs, while the bias is not obvious among non-EGFR modulated pairs 
(Fisher’s exact test, p-value = 9.7e-6). PABPC4L is also identified as a positive miRNA 
modulator (Fisher’s exact test, p-value = 1.0076e-7); all (25/25) modulated miRNA-
target interactions are better correlated when PABPC4L is highly expressed. PABPC4L is 
a poly-A tail binding protein, and it may be interacting with another poly-A tail binding 
protein, PABP1, and involved in recruiting CCR4-NOT complex and induce subsequent 
mRNA degradation. The only known PABPC4L interacting protein is PAIP1, and PAIP1 
is highly similar with EIF4G1, a eukaryotic translation initiation factor. This implies 




                                   TCGA                                              METABRIC 
Figure 5.5 miRNA-target pairs have better relationship when AGO2 is highly 
expressed. 
 In TCGA BRCA and METABRIC, miRNAs and targets are negatively correlated 
when AGO2 is highly expressed 
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In METABRIC, there are seven predicted miRNA activity modulators have 
significant mode of action: UBE2C, EGFR, INO80E, FYN, BTRC, TRIM29 and 
RNF150 (Fisher’s exact test, p < 5e-2). Notably, only EGFR, FYN and TRIM29 are also 
predicted as miRNA modulators using TCGA data set. Moreover, all three modulators 
increase the miRNA activity in TCGA BRCA and METABRIC (Figure 5.4), suggesting 
EGFR, FYN and TRIM29 are high confidence candidates. To test if candidate miRNA 
modulators have widespread effects on more miRNA-target interactions, we took over 
60000 predicted miRNA-target interactions from Targetscan with context score higher 
than 80 and examine the consistence of our prediction. In total, 24126 and 23173 
predicted miRNA-target pairs could exist (mutual information, p-value < 1e-2 and 
spearman correlation < 0) in TCGA BRCA and METABRIC, respectively. First of all, I 
apply the mode of action analysis on AGO2, the core component in miRNA-mediated 
regulation. More than 2000 predicted miRNA-target interactions can be modulated by 
AGO2 in our prediction (conditional mutual information, p < 1e-5). The mode of action 
analysis clearly showed the anti-correlation between miRNA and target when AGO2 is 
highly expressed, and the anti-correlation between miRNAs and targets disappear when 
AGO2 is low (Wilcoxon signed-rank test, p-value < 2.2e-16) (Figure 5.5). The result 
from AGO2 agrees with our hypothesis; the essentiality of AGO2 was clearly depicted in 
the mode of action analysis. In our prediction, EGFR, FYN and TRIM29 regulate 2981, 
672 and 1590 predicted miRNA-target interactions in TCGA BRCA data set, and they 
modulate 643, 386 and 203 predicted pairs in METABRIC. The mode of action analysis 
shows they all still act as positive miRNA modulators in the much bigger collection of 
predicted miRNA-target pairs using two independent breast cancer data sets. The 
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distribution of spearman correlation between the predicted miRNA-target pairs is 
significantly shifted when EGFR, FYN and TRIM29 are highly expressed, while EGFR, 
FYN and TRIM29 are lowly expressed, the distribution of correlation is centered on 0 
(Wilcoxon signed-rank test, p-value < 2.2e-16). It suggests they all have wide spread 
effect on miRNA-mediated post-transcriptional regulation. EGFR is a membrane-
associated tyrosine kinase, and it phosphorylates downstream targets to initiate several 
signaling pathway, including MAPK and AKT pathway. AGO2 is the core protein of 
miRISC complex. Not only binds to mature miRNAs and protect them from turnover, 
AGO2 also induces endo-nucleic cleavage when miRNAs perfectly match to their target 
mRNA. The relationship between EGFR and AGO2 was established by Adams et al. in 
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2009. They showed the expression of AGO2 is upregulated in estrogen receptor (ER) α-
negative breast cancer cell lines compared to (ER) α-positive breast cancer cell lines. In 
the ERα-negative cell line, MDA-MB-231, AGO2 protein level was severely abrogated 
upon silencing EGFR. We also observed the significant reduction of AGO2 mRNA level 
while knocking down EGFR in another ERα-negative cell line, HCC1395, using EGFR-
specific siRNA. Due to the centrality and essentiality of AGO2 in miRNA-mediated 
regulation, EGFR ranked as the top candidate in our analysis.  
Besides breast cancer, we also used gene and miRNA expression profile from 
TCGA glioblastoma data set to identify miRNA activity modulators. As discussed before, 
to identify miRNA activity modulators, we restricted our analysis to candidate 
         
                           
 
Figure 5.6 EGFR, FYN and TRIM29 affect the relationship of predicted miRNA-
target pairs.  
EGFR, FYN and TRIM29 are candidate positive miRNA modulators for predicted 
miRNA-target interactions in TCGA BRCA and METABRIC 
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modulators of literature-validated miRNA-target interactions. Because prediction of 
individual miRNA targets is still inaccurate, we could not rely on the robust statistics 
afforded by large miRNA programs, as used when predicting sponge modulators. Even 
with this substantial limitation, Hermes could identify 148 miRNA activity modulators, 
suggesting that this number may increase substantially once a more comprehensive, high-
accuracy miRNA target network is available. To experimentally confirm nonsponge 
modulator candidates inferred by our analysis, we selected three interactions, two 
affecting PTEN and one affecting RUNX1. These include WIPF2, as a miR-mediated 
regulator of RUNX1, and PALB2 and WNT7A, as miRNA-mediated regulators of PTEN 
(Figure 5.8 A). Both PTEN and RUNX1 are known drivers of gliomagenesis (Carro et al., 
2010; Verhaak et al., 2010), and genes that regulate their expression may play a role in 
this disease. 
Upregulation of WNT7A by transfection of its cDNA, which lacks both 5’ and 
3’UTRs, led to 1.5-fold upregulation of PTEN or PTEN 3’ UTR luciferase activity 
""""""""""""""""""""" "
"
Figure 5.7 EGFR level affects AGO2 in breast cancer basal cell lines.  
Silencing EGFR in MDA-MB-231 and HCC1143 both repress the AGO2 level.  
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(Figures 5.8 B and 5.8 E), suggesting that, as predicted, WNT7A regulation of PTEN is 
miRNA dependent, but not sponge mediated. Silencing PALB2 led to a 1.5-fold 
upregulation of PTEN or PTEN 3’UTR luciferase activity (Figures 5.8 C and 5.8 E), and 
silencing WIPF2 led to a 3-fold upregulation of RUNX1 expression and 2-fold 
upregulation of RUNX1 3’UTR luciferase activity (Figures 5.8 D and 5.8 F), both 
consistent with computational predictions of miRNA-mediated downregulation. 
Consistent with miRNA-dependent regulation, DROSHA and DICER silencing (Figure 
5.8 G) abrogated PTEN and RUNX1 regulation by WNT7a/PALB2 and WIPF2, 
respectively (Figures 5.7 E and 5.7 F). Expression of validated miRNAs targeting these 
genes, such as miR-21 (WNT7A), miR-106a (PALB2), and miR-17-5p (WIPF2), were 




Figure 5.8 validation of miRNA modulator and PTEN in SNB19. "
(A) Validated miRNA modulators include WNT7A and PALB2 (predicted to induce 
miR- dependent upregulation and downregulation of PTEN, respectively) and WIPF2 
(predicted to induce miR-dependent downregulation of RUNX1).  
(B) PTEN 3’UTR luciferase activity and activity of the empty luciferase vector were 
measured at 24 hr following ectopic expression of pCMV-WNT7A or empty vector 
pCMV. 
(C) PTEN 3’UTR luciferase activity and activity of the empty luciferase vector were 
measured at 24 hr following siRNA-mediated silencing of PALB2 versus nontarget 
siRNA. 
(D) RUNX1 3’UTR luciferase activity) and activity of the empty luciferase vector at 
24 hr following siRNA- mediated silencing of WIPF2 and nontarget (NT5) siRNA. 
(E) qRT-PCR analysis of PTEN gene expression fold change at 24 hr following 
ectopic expression of WNT7A and siRNA mediated silencing of PALB2 without 
(left) and with (right) siRNA-mediated silencing of DROSHA and DICER. 
(F) qRT-PCR analysis of RUNX1 gene expression fold change at 24 hr following 
siRNA-mediated silencing of WIPF2 without (left) and with (right) siRNA-mediated 
silencing of DROSHA and DICER. 
(G) Efficiency of WNT7A ectopic expression and of siRNA-mediated silencing of 
PALB2, WIPF2, DICER, and DROSHA, measured by qRT-PCR analysis. 
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5.4 Discussion  
MiRNA-mediated regulation represses target gene expression by mRNA 
degradation and translational repression. In addition to core miRISC component, such as 
AGO2 or GW182, dozens of other proteins also contribute to the regulation of miRNA 
activity. These proteins modulate miRNA efficiency by interacting with miRISC 
components or binding to target mRNA in order to compete against or facilitate miRISC. 
Since there are many proteins bind to mRNA at 3’UTR or interact with miRISC 
components, we hypothesize that there are many miRNA modulators to be identified in 
different contexts. This is the first attempt to computationally identify miRNA 
"""""""""""""""""""" "
Figure 5.9. Nonsponge modulators have little effect on the expression of 
regulating miRNAs.  
The qPCR expression of validated targeting miRs found to be significantly modulated 
are unchanged relative to their targets by pCMV-WNT7A transfection or PALB2 and 
WIPF2 silencing. Data are represented as mean ± SEM. 
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modulators. Notably, we obtained very similar predictions from two independent data 
sets, implicating the candidate genes are conserved and active in breast cancer context. 
In our analysis, EGFR, FYN and TRIM29 all predicted as positive miRNA 
modulator using TCGA BRCA and METABRIC data. EGFR, a membrane-associated 
tyrosine kinase, phosphorylate downstream targets and stimulates various cell signaling 
pathways that controls cell proliferation, apoptosis and survival. Amplifications or 
somatic mutations of EGFR are often identified in multiple tumors, such as glioblastoma 
and non-small cell lung cancer, and dysregulation of EGFR is strongly implicated in the 
biology of human epithelial malignancies. In this analysis, we suggest there could be a 
novel role of EGFR to influence the downstream targets using different mechanism, 
miRNA-mediated regulation. We found the upregulation of EGFR associates with better 
relationship (negative correlation) between miRNAs and their target mRNAs. The 
phenomenon not only presents in validated miRNA-target interactions; it applies to 
whole miRNAome as well. Over 80% of predicted miRNA-target interactions modulated 
by EGFR are better correlated (negatively) under high EGFR context. We found the 
expression of the core component of miRISC, AGO2, is regulated by EGFR. Therefore, it 
may explain EGFR have a widespread influence on miRNA regulation. Besides 
regulating AGO2 expression, EGFR also interact and phosphorylate AGO2 at Try393 in 
response to hypoxia. Phosphorylation at Tyr393 on AGO2 interferes the interaction 
between DICER1 and AGO2; therefore, it interferes miRNA biogenesis by preventing 
several miRNA-miRNA* duplexes being transferred from DICER1 to AGO2. The 
miRNAs with long hairpin loop are particularly affected by Tyr393 phosphorylation, 
such as miR-31, miR-192 and miR-193a-5p. The p-Y393-AGO2 is significantly 
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upregulated during tumor progression and enriched in hypoxic tumor area. More 
importantly, breast cancer patients with higher expression of p-Y393-AGO2 have 
significantly poor survival rate. 
Tyrosine kinases can be classified into two categories: receptor and nonreceptor 
tyrosine kinase. Receptor kinase, such as EGFR and VEGFR (vascular endothelial 
growth factor receptor), can be stimulated by extracellular ligands and activate 
downstream targets. FYN is a membrane-associated nonreceptor tyrosine kinase and 
belongs to Src family kinases. FYN can serve as mediator of growth factor-induced AKT 
activity: knocking down FYN together with Src abolished the activation of AKT by EGF. 
FYN is found to be upregulated in various types of cancer, including melanoma, 
glioblastoma multiforme and squamous cell carcinoma of the head and neck. More 
intriguingly, overexpression the dominant negative FYN reduced primary tumor weights 
in a mouse squamous cancer model. Similar with EGFR, we proposed that FYN also 
plays an important role in miRNA-mediated regulation by improving miRNA efficiency. 
Over 80% of FYN-modulated miRNA-target interactions have better relationship when 
FYN is highly expressed, which implicated the core component of miRISC could be 
downstream substrate of FYN. 
At present, over a dozen of proteins are known to be able to modulate miRNA 
activity. Several validated miRNA modulators belong to TRIM-NHL family, possessing 
E3 ubiquitin ligase activity, including Mei-P26, TRIM32, NHL-2 and TRIM71. They can 
act as positive or negative modulators of miRNA. Mei-P26 in Drosophila melanogaster 
is a negative miRNA modulator, and its homolog in C. elegans is NHL-2. Mei-P26 
mutant showed aberrant cell proliferation and differentiation in female germline of D. 
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melanogaster, and the phenotype was partially caused by hyperactivity of miRNA 
regulation. Mei-P26 interacts with AGO1, which is the Argonaute protein mainly 
responsible for miRNA activity in fly, but the detailed mechanism of Mei-P26 remains to 
be clarified. Interestingly, while Mei-P26 interferes miRNA pathway, its homolog in C. 
elegans, NHL-2, promotes miRNA efficiency. NHL-2 interacts with AGO and GW182 
physically and genetically, and it also interacts with another P-body component, CGH-1. 
In C. elegans, loss of nhl-2 weakens the repression of let-60 and cog-1 while the levels of 
let-7 and lsy-6 remain unaffected. Trim71, also known as Lin41, is an evolutionary 
conserved E3 ubiquitin ligase. It is found to induce ubiquitylation and proteasome-
mediated degradation of Ago2 in mice. Overexpression and knocking down of Trim71 
leads to decrease and upregulation in the level of Ago2, respectively, indicating Trim71 
represses endogenous Ago2 level. Another validated miRNA modulator, Trim32, was 
also found to interact with AGO1 in mice. The interaction enhances the miRNP activity 
and increases the miRNA efficiency. TRIM32 carries NHL domain, RING domain (E3 
ubiquitin ligase) and BBOX domain; however, it only ubiquitinates the transcription 
factor, c-myc, via RING domain to induce protein degradation. TRIM32 interacts with 
AGO1 via NHL domain, like Mei-P26, but TRIM32 and Mei-P26 have opposite effects 
upon interacting with AGO1, suggesting other domains are involved in determining the 
mode of action of AGO1 interacting protein. We predicted TRIM29 as a positive 
regulator; almost 90% of TRIM29-modulated predicted miRNA-target interactions have 
better relationship when TRIM29 is highly expressed. Currently, our understanding about 
TRIM29 is still very limited. TRIM29 is evolutionary conserved in vertebrates and 
carries a BBOX domain that can be used as a mediator of protein-protein interaction. 
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Here we proposed TRIM29 may also interacts with miRISC core components and 






This thesis demonstrates the first attempt to genome-wide infer miRNA 
biogenesis regulators and activity modulators. The first two chapters described the 
motivation of this analysis and reviewed the current knowledge regarding to the 
regulation of miRNA biogenesis and miRNA efficiency. Chapter 3 described how we 
utilized high-throughput data (ENCODE and FANTOM) to obtain highly confident 
intragenic miRNAs that are co-transcribed with host mRNAs. Furthermore, we showed 
that despite miRNA and mRNA are in the same transcription unit, the relationship 
between many host-miRNA pairs are still very subtle, implicating many intragenic 
miRNAs’ level are under extensive regulation. Chapter 4 demonstrated the effort to 
computationally and experimentally screen for miRNA biogenesis regulators. The 
algorithm, MIRAGE, identified several validated miRNA biogenesis regulators, 
including LIN28, ILF3 and ERN1. We validated several candidates throughout the 
prediction and showed their ability to affect miRNA processing at the post-transcriptional 
stage. The pri-miRNA binding activity of SMAD6 was also biochemically demonstrated 
in this chapter. Additionally, I use PAR-CLIP data from public domain to show IGF2BP3 
interacts with miRNA in HEK293 cell. From the IGF2BP3-interacting miRNAs, we also 
identify the regulation of IGF2BP3 on PTEN through miRNA program. Chapter 5 
showed the result of screening for miRNA activity modulators. We developed an 
algorithm to infer miRNA activity modulators using the expression profile of miRNA and 
targets. The results showed EGFR, FYN and TRIM29 are potential positive miRNA 
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modulators in breast cancer context. Over 80% of predicted miRNA-target pairs are 
better correlated negatively when these three genes are highly expressed. The detailed 
biochemical mechanism still needs to be studied. We also demonstrated that, in 
glioblastoma, PTEN level is not only modulated by miRNAs but also by other miRNA 
modulators, such as PALB2, WNT7A and WIPF2. 
In summary, we carried out a series of analysis in order to understand the post-
transcriptional regulation of miRNA biogenesis and miRNA function. MiRNAs are 
known to be involved in many biological pathways, and 30% to 60% of transcriptome are 
under miRNA modulation. Therefore, this analysis could lead us to a clearer view of 
miRNA profile. Most of miRNA regulators are able to modulate a subset of miRNAs or 
miRNA-target interactions, which implicate the dysregulation of components in miRNA 
pathway may lead to severe defects, such as developmental abnormality, embryonic 
lethality and tumorigenesis (Kumar, Lu et al. 2007; Stefani and Slack 2008; Yi, Pasolli et 
al. 2009). 
Lu et al. first profiled miRNA expression from various tumor types and the 
adjacent normal tissues and showed that miRNAs are generally less abundant in tumors 
compared to their normal tissue counterparts (Lu, Getz et al. 2005). This finding leads to 
the proposal that there are defects in miRNA biogenesis pathway, which may lead to 
tumorigenesis. Subsequent studies showed around 27% of various tumors are found to 
have a hemizygous deletion in DICER1 (Kumar, Pester et al. 2009). Additionally, 
targeting DICER1, DROSHA and its cofactor DGCR8 knocks down global miRNA 
expression and increases the oncogenic potential of cancer cell lines and accelerates the 
tumor formation (Kumar, Lu et al. 2007). 
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Aberrant expression of DICER1 leads to the impaired miRNA processing has also 
been shown to increase the rate of tumor formation in two different cancer mouse models, 
a KRAS-driven lung cancer and an Rb-driven retinoblastoma (Kumar, Pester et al. 2009; 
Lambertz, Nittner et al. 2010). Therefore, DICER1 is considered a haploinsufficient 
tumor suppressor, requiring partial deletion for its associated tumorigenesis phenotype. 
The phosphorylation of the DICER1 cofactor TARBP2 by the mitogen-activated protein 
kinase ERK enhances pre-miRNA processing of oncogenic miRNAs, such as miR-21, 
and decreases production of tumor suppressor let-7a (Paroo, Ye et al. 2009). Moreover, 
TARBP2 is mutated in some colon and gastric cancers with microsatellite instability, and 
TARBP2 frameshift mutations correlate with DICER1 destabilization; in cell lines and 
xenografts with TARBP2 mutations, reintroduction of wild type TARBP2/DICER1 
slowed tumor growth (Melo, Ropero et al. 2009; Garre, Perez-Segura et al. 2010). Finally, 
DICER1 was also recently implicated as a metastasis suppressor (Garre, Perez-Segura et 
al. 2010). Another core miRNA regulator, DROSHA, was found to be a predictor of 
breast cancer patient prognosis. A gradual loss of cytoplasmic DROSHA was found to 
gradually lose during tumor progression from ductal carcinoma in situ to invasive or even 
metastatic tumor. Loss of cytoplasmic DROSHA is associated with BRCA1 and ESR1 
expression in breast cancer (Khoshnaw, Rakha et al. 2013). Note that miRNA precursors 
are processed by DROSHA in the nucleus and then the pre-miRNAs are transported to 
cytoplasm by XPO5; therefore, the connection between miRNA and cytoplasmic 
DROSHA needs to be further examined. 
Besides the core components in the miRNA biogenesis pathway, post-
transcriptional regulators also associate with tumor initiation and progression. LIN28A is 
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the most well studied miRNA biogenesis regulator. LIN28A blocks processing of tumor 
suppressor pri-let-7 in nucleus and pre-let-7 in cytoplasm by recognizing a motif on the 
terminal loop, thus maintaining expression of genes that drive self-renewal and 
proliferation; tumors that express LIN28A were indeed shown to be poorly differentiated 
and more aggressive than LIN28A-negative tumors (Newman, Thomson et al. 2008; 
Piskounova, Viswanathan et al. 2008; Rybak, Fuchs et al. 2008; Viswanathan, Daley et al. 
2008; Viswanathan, Powers et al. 2009). Another example is heterodimer DDX5/DDX17. 
The helicases DDX5 and DDX17 both carry DEAD box can stimulate the processing of 
one third of all murine miRNAs by interacting with DROSHA and miRNA precursors or 
by acting as a scaffold protein to recruit other factors, such as TP53, SMAD5, to the 
DROSHA complex. Dimerization of DDX17 and DDX5 RNA helicases through 
interactions is mediated by the tumor suppressor TP53. Interactions of DDX5/DD17 and 
TP53 to the DROSHA-DGCR8 complex facilitate the conversion of some pri-miRNAs to 
pre-miRNAs. Specifically, the DDX5-mediated interaction of the DROSHA complex 
with the tumor suppressor TP53 was shown to have a stimulatory effect on the tumor 
suppressor pri-miR-16-1, pri-miR-143 and pri-miR-145 processing in response to DNA 
damage in cancer cells (Suzuki, Yamagata et al. 2009). Thus, mutations and deletion of 
TP53, which are often observed in multiple types of malignancies, might lead to a 
widespread decrease in pre-miRNA production. Oncogenic R-SMADs (SMAD1, 
SMAD3 and SMAD5), downstream effectors of the TGF-β/BMP2 pathway, have been 
shown to modulate DROSHA-mediated miRNA maturation through interaction with 
DDX5 and target pri-miRNAs. The binding of SMADs to miRNA precursors promotes 
the expression of a subset of miRNAs bearing the R-SMAD binding motif, including 
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oncogenic miR-21, once TGF-β pathway is stimulated. KSRP promotes the biogenesis of 
a subset of miRNAs, including let-7a, by serving as a component of both DICER1 and 
DROSHA complexes affecting proliferation, apoptosis and differentiation (Davis, 
Hilyard et al. 2008; Trabucchi, Briata et al. 2009). In a final example, inactivating 
mutations of XPO5 in tumors with microsatellite instability result in the nuclear retention 
of miRNAs (Melo, Moutinho et al. 2010). Restoration of XPO5 function reverses the 
impaired export of pre-miRNAs and has tumor suppressor features. 
In addition to the miRNA regulators mentioned above, we identified IGF2BP2, 
IGF2BP3 and SMAD6 as novel miRNA biogenesis regulators. Their expression level 
associates with patient prognosis. High level of IGF2BP2 and IGF2BP3 associate with 
poor-prognosis of patients with glioblastoma. We also proved IGF2BP3 suppress the 
tumor suppressor gene, PTEN, via miRNA pathway, and knocking down IGF2BP3 slows 
down the proliferation of SNB19. More importantly, the clinical data from 
REMBRANDT database showed the level of IGF2BP3 is associated with the prognosis 
glioblastoma patients. Patients with high IGF2BP3 level (>2X) has worse prognosis than 
patients with normal or low IGF2BP3 level. 
EGFR was identified as a candidate miRNA activity modulator in breast cancer. 
From computational screening using validated and predicted miRNA-target interactions, I 
showed EGFR increases miRNA activity. Preliminary experimental validation 
demonstrated AGO2 is positively regulated by EGFR, and this observation could explain 
why EGFR possesses a strong and broad effect on miRNA-mediated regulation. EGFR is 
highly expressed in basal subtype, but not in luminal A and B subtype of breast cancer. 
Notably, patients in basal subtype have worse prognosis compared to patients in luminal 
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A and B subtype. It is important to know if EGFR contributes to the bad prognosis of 
breast cancer patients in basal subtype through miRNA-mediated regulation. 
Regulatory network usually contains only interactions between transcription 
factor and targets, protein and protein, signaling proteins and substrates. The knowledge 
we obtained from this study provides a useful resource for miRNA biology, systems 
biology and oncology. This resource can be utilized for building a complete regulatory 
network and searching for potential therapeutic targets. This method can also be applied 
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